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Streptomyces, Gram positive filamentous bacteria, are very important organisms due to their 
capability of producing a variety of useful secondary metabolites with many biological 
activities and applications such as antibiotics, anticancer drugs and antioxidants. The increase 
in resistant pathogens, emergence of new diseases and toxicity of drugs that are currently used 
makes the urgent search to find new bioactive compounds in the medical industry to be of 
major importance. UAE is an under explored habitat that may have the potential to harbour 
novel Streptomyces strains producing diverse natural products. The main aim of the study is to 
isolate novel Streptomyces species from terrestrial habitats. Six Streptomyces strains (CSK1, 
CSK3, CSW2, CSU1, CSU2 and CSG1) were found to produce antimicrobial metabolites 
against Escherichia coli, Staphylococcus aureus, Candida albicans, Saccharomyces cerevisiae 
and Escherichia coli-ESBL using the well diffusion method. Phylogenetic analysis of the 16S 
rRNA sequence confirmed the identification and novelty of the six isolates to the genus of 
Streptomyces. The cytotoxicity of the extracts was investigated on HeLa cancer cell line by 
MTT assay and DAPI staining where some of the isolates inhibited the growth of HeLa cells 
in a concentration-dependent manner and caused apoptosis observed by DNA fragmentation 
and chromatin condensation. Cultivating the isolates with Bacillus subtilis and N-
acetylglucosamine resulted in one isolate acquiring cytotoxic activity against HeLa cells which 
was not observed in the monoculture. Cultivation with γ-Butyrolactone led to either 
enhancement or inhibition of antimicrobial and cytotoxic activity. Genomic sequencing and 
liquid extraction surface analysis mass spectrometry (LESA-MS) techniques were performed 
to identify biosynthetic genes produced by the isolates. The genome of the isolates was 
sequenced and a variety of biosynthetic gene clusters were predicted by antiSMASH analysis. 
Finally, LESA-MS was performed as a novel technique of direct sampling from the bacterial 
colonies. Distinct changes in mass profiles were generated between the uninduced and induced 
isolates which was observed as appearance, disappearance or increase of intensity in the 
produced peaks. The masses of the biosynthetic gene clusters produced by antiSMASH were 
additionally confirmed by LESA. Based on the results of this study, we conclude that these 
isolates are capable of producing antimicrobial and anticancer metabolites, varied and distinct 
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Streptomyces are Gram positive filamentous bacteria, capable of forming spores and aerial 
mycelium. Streptomyces belongs to family Streptomycetaceae and they are of major interest 
due to their ability to produce bioactive compounds with antimicrobial activity (Goodfellow 
& Fiedler, 2010). About 40-50% of the actively produced secondary metabolites come from 
actinomycetes and about 70-80% of these are produced by Streptomyces (Berdy, 2012), which 
makes it a significant genus. More than 6,000 bioactive metabolites produced by different 
species of Streptomyces possess some form of inhibitory activity that has been utilized in 
antibiotics, antifungals, antiviral or anticancer agents (Berdy, 2005).  
Streptomyces are known as producers of medicine as they are the source for the production 
of many secondary metabolites with clinical applications some of which are antimicrobial 
(erythromycin, streptomycin) and anticancer (bleomycin and doxorubicin) (Demain and 
Sanchez, 2009) which signifies their importance and interest in isolating them. The emergence 
of multidrug-resistant pathogenic bacteria has increased the search for new antibiotics from 
natural sources with low or no side effects (Malapaka et al., 2007). Streptomyces that have 
inhibitory activity may produce many antibiotics that can be different in their mode of action, 
toxicity, chemical nature and their therapeutic potentials. Some Streptomyces may produce 
more than one antibiotic such as S. griseus which produces streptomycin and dihydrogranticin 
(Procópio et al., 2012) or different species of Streptomyces may produce the same antibiotic 
(e.g., actiomycin and streptothricin) (Harir et al., 2018). In addition, some antibiotics have 
more than one mode of application such as arenimycin which is used as antibacterial and 
anticancer compound. Streptomyces have many other applications such as production of 
enzymes (e.g., lipases, cellulases and amylases) (Hiramatsu and Ouchi, 1963), herbicides (e.g. 
herbicidine) (Shelton et al., 1996) and production of vitamin B12 (Hall et al., 1953), and 
therefore playing an important role in bioremediation and degradation of aromatic compounds. 
Streptomyces can be found in soil, marine sediment and freshwater. Yet, most of the 
antibiotics that are found in the market were produced from terrestrial Streptomyces, when in 
contact with a surface Streptomyces reproduce by spores that are formed by specific aerial 
mycelium which is synchronized with antibiotic production (Zhu et al., 2014). Their existences 
and dominance depend on many factors such as temperature, pH, nutrients, climate, season, 




Searching for secondary metabolites from natural habitat is still of great interest, even with 
the emergence of the synthesis of synthetic antibiotics, as it is a rich and unlimited source for 
finding new antimicrobial agents with new structures and chemical properties (Baltz, 2006). 
Multidrug resistance of pathogenic organisms, resistance and toxicity of chemotherapeutic 
drugs and unfavourable side effects are all playing a vital part in the importance of finding 
novel bioactive compounds.  
 
 Characteristics and Life Cycle of Streptomyces  
Streptomyces are aerobic microorganisms with DNA containing high GC content. They 
have many morphological, biochemical and physiological properties that make them 
significantly different from other microorganisms indicating formation of spores and 16S 
rRNA partial sequences (Korn-Wendisch and Kutzner, 2006).  They are found in many 
environments especially soil and marine habitats. Morphologically, they are similar to fungi 
as they grow by tip extension which leads to the formation of branched hyphae. Under nutrient 
rich conditions, Streptomyces produce heavy vegetative mycelium and cell division takes place 
by the formation of cross walls separating each hyphae into individual compartments 
(Anderson and Wellington, 2001). As such, this makes Streptomyces multicellular organisms 
as each compartment have many copies of the chromosome (Claessen et al., 2014). 
Streptomyces have a complex life cycle in which they reproduce asexually by sporing. The 
life cycle begins when a spore is inoculated into a nutrient medium using starch as the primary 
source of carbon and casein as the nitrogen source leading to the germination of the spore from 
the dormant state into one or two germ tubes forming the aerial hyphae (Figure 1.1). Under 
environmental stresses such as lack of nutrients they move from vegetative state (substrate 
mycelium) into sporulation phase in the form of aerial multinucleated mycelium. The germ 
tubes expand and form branches of vegetative mycelium. Growth of the colony leads to the 
hyphae breaking through the medium, extending into the air (Flardh and Buttner, 2009).  The 
substrate hyphae have a diameter of about 0.5-1.0 µm. Wavy, straight or helical chains of 
sporophores come out into the surface (Chater, 1993).  
In the environment, soil microorganisms go into a dormant state under harsh conditions 
where growth stops, replication ceases and they become metabolically inactive and they 
differentiate into spores known as either arthrospores or exospores depending on the 
microorganism producing them (Bobek et al., 2017). Endospores produced by Bacillus and 
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Clostridia are resistant to ultraviolet radiation, heat and desiccation (Setlow, 2007; Galperin et 
al. 2012). These organisms have very thick surface structures and low water levels that allows 
them to survive harsh conditions (Henriques and Moran, 2007). However, the streptomycete 
arthrospores have thick coat (Neiman, 2005), heat shock proteins and macromolecules 
protected by sugars such as trehalose (Wyatt et al., 2013). The main function of the spores in 
Streptomyces is to shield or protect genetic information during stressful conditions and then 
spread it into other areas by air or water. Nutrient depleted conditions cause the cells to down 
regulate processes that require energy and upregulates stress response and survival genes 
(Sivapragasam and Grove, 2019) leading to the production of secondary metabolites. 
Streptomyces use many extracellular hydrolytic enzymes such as amylase, cellulase and 
chitinase to decompose decaying or dead organic compounds (Kieser et al., 2000) to get the 
needed nutrients for growth. Yet, when nutrient conditions are scarce aerial mycelium is 
formed and then differentiates into the formation of spores. This morphological change results 
in metabolic changes leading to the production of secondary metabolism. Many studies have 
shown the direct link between sporulation and the production of secondary metabolites such 
as the production of actinorhodin in Streptomyces coelicolor A3(2) (Bibb, 2005). 
Streptomyces are slow-growing microorganisms and have an earthy odour due to the 
presence of geosmin, a volatile metabolite, produced by the bacteria (Juttner and Watson, 
2007). Colonies are powdery (velvety) and leathery in texture. The pigments produced by the 
bacteria give the vegetative and aerial mycelium its colour (Flardh and Buttner, 2009). In this 
project, the Streptomyces that were isolated have colonies with leathery texture, earthy smell 







Figure 1. 1 Life Cycle of Streptomyces 
Sporulation in the life cycle of Streptomyces. Adapted from Berdy, 2016. 
 
 Streptomyces Genome  
The size of the Streptomyces genome is approximately between 6 and 10 Mb, such a large 
bacterial genome is due to the complex life cycle of the organism and the variation in size is 
due to the diversity of biosynthetic gene clusters in the genome of Streptomyces species. 
Studies have shown that Streptomyces contain accessory secondary metabolites that are strain 
specific which could have been obtained by intraspecies horizontal gene transfer (Sottorff et 
al., 2019; Vicente et al., 2018). The genetic information of Streptomyces is located on a linear 
chromosome associated with either a linear or circular plasmid depending on the species. This 
linear chromosome is made of a core (central) region and arms which end by terminal inverted 
repeats (TIRs) with terminal proteins binding to the 5’ end of the DNA. All essential genes 
that are responsible for replication, transcription, translation and protein synthesis are located 
in the core along with genes involved in primary metabolism while all the non-essential genes 
such as bioactive compounds and hydrolytic exoenzymes are located in the variable arms 
(Bentley et al., 2002). In addition, transposases and insertion sequences (mobile sequences) 
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are also in the arms (Choulet et al., 2006). More than 10% of the Streptomyces genome is 
involved with the synthesis of bioactive compounds (Carlson et al., 2015). Among the 
sequenced Streptomyces genomes, it is found that about half of the chromosome comprises a 
core region which is the most conserved region within Streptomyces species (Choulet et al., 
2006; Ikeda et al., 2003; Ohnishi et al., 2008).  
Streptomyces have a highly complex regulatory systems that causes morphological and 
metabolic pathways changes, and regulate growth rates in response to environmental changes 
(De Bruijn, 2016) including secondary metabolites production which are strongly regulated at 
the transcription level in Streptomyces (Sun et al., 2017). These regulatory systems act based 
on the transcription of specific genes (Rebets et al., 2018). There are many regulatory proteins 
in Streptomyces, many of which are sigma factors (factors that initiate transcription in bacteria) 
along with other proteins that are involved in transport, decomposition of nutrients and 
production of bioactive compounds (Bentley et al., 2002). RNA polymerase (RNAP) plays an 
essential role in transcription. Sigma factors in RNAP determines specific promoter elements 
allowing the transcription initiation of specific sets of genes (Kang et al., 1997). All bacteria 
have essential sigma factors that designates the expression of housekeeping genes and non-
essential sigma factors with many functions in response to cell differentiation and stresses 
(Paget, 2015). This explains why Streptomyces genomes have many genes coding for RNA 
polymerase sigma factors and many systems of transcriptional regulators (Rückert et al., 2015). 
For example, S. coelicolor contains 66 chromosomal sigma factor genes while E. coli contains 
7 only (Paget et al., 2002; Gruber and Gross, 2003).  
Advances in genomic sequencing along with the decrease in its cost has allowed us to 
identify biosynthetic gene clusters of specific Streptomyces species. Only, 3% of the bioactive 
compounds have been discovered to date and this is mainly due to the in-vitro culturing 
conditions leading to reduced production (Gontang et al., 2010). Genomic sequencing has 
shown that Streptomyces are capable of producing many secondary metabolites but only few 
show activity in the laboratory (Hoshino et al., 2015). 
 
 Secondary Metabolites in Streptomyces  
Metabolites are small molecules that are produced from a variety of living things (Krause 
and Tobin, 2013). These molecules are produced either by primary metabolism or by secondary 
metabolism (Berdy, 2005). Primary metabolites are chemicals that are usually found in all 
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biological processes such as nucleic and fatty acids and polysaccharides, while secondary 
metabolites are molecules with low molecular weights that are produced as a defence 
mechanism to protect the cells from other surrounding organisms that compete for nutrients or 
in morphological differentiation (Thirumurugan et al., 2018) and these secondary metabolites 
are increasingly referred to as “specialised metabolites” in the literature. Therefore, microbial 
secondary metabolites are produced as an adaptation mechanism to the surrounding 
environment and they act at as signalling or defence molecules (Chadwick and Whelan, 2008). 
Therefore, an organism’s secondary metabolites profile can be different according to the 
habitat they occupy.  
The most distinct property of Streptomyces species is the existence of biosynthetic gene 
clusters, these clusters encode to proteins leading to the production of secondary metabolites 
(Nett et al., 2009). They are known as “Secondary” because they are not involved in cell 
division and don’t affect the growth of the organism. Most secondary metabolites are produced 
during the Streptomyces life cycle when they progress from a vegetative state into sporulation 
and the formation of aerial multinucleated mycelium (Dyson, 2011). This morphological 
differentiation takes place due to stressful environmental conditions such as nutrient depletion, 
space, competition with other organism, temperature, pH and salt changes or as a reaction to 
physiological signalling molecules (Bibb, 2005). Secondary metabolism in Streptomyces 
usually happens in the stationary phase of the organism’s life cycle. 
Most of the secondary metabolites produced by Streptomyces have medicinal properties 
which are largely antibiotics (e.g. erythromycin) plus antifungal (e.g. amphotericin B) and 
anticancer (e.g. Doxorubicin) (Newman and Cragg, 2007). Most of the discovered secondary 
metabolites come from soil Streptomyces. This terrestrial habitat has been a useful and 
important source for many years. Although the discovery of new Streptomyces species and 
bioactive compounds has decreased considerably in recent years, there are still unexplored 
areas such as the Middle East and specifically UAE that could still be a potential source for 
discovering novel secondary metabolites.  
  The marine environment is also a rich resource for bioactive compounds, the extreme 
environment of salinity and pressure causes actinomyces to adapt and produce natural 
compounds. Marine Streptomyces have been of great interest as an unusual source of 
chemically diverse secondary metabolites and novel bioactive compounds (Juhnke et al., 
1987).  
Recently, the search for marine actinomyces have been of great interest because they have the 
ability to endure severe habitats (Subramani and Aalbersberg, 2012). They have rare metabolic 
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and physiological abilities making them capable of producing novel bioactive compounds 
(Williams, 2009). However, a major concern involving marine actinomyces is the difficulty to 
culture these organisms, as these organisms are halophiles and require sea salts for culturing 
(Thykaer and Nielsen, 2003). It has been actually a major challenge in this project to grow 
marine Streptomyces that could be resolved by optimizing their isolation, growth (Busscher et 
al., 2005; O'Driscoll et al., 2008; Wang et al., 2005) and fermentation process for the 
production of bioactive metabolites (Thykaer and Nielsen, 2003; Tsai et al., 2013). 
 
 Biosynthesis of Secondary Metabolites  
The processes of biosynthesis from microbial secondary metabolites clusters are 
divided into: supply of building blocks, building blocks assembly and precursor molecule 
tailoring to produce the final product (Flickinger, 2010). Some of the biosynthetic gene clusters 
(BGCs) present in the Streptomyces genome have been found to play a major role in the 
production of secondary metabolites. They are produced when the organism shifts from the 
substrate mycelium phase to the sporulation phase. A gene cluster is composed of genes that 
are located next to each other in the organism’s chromosome and are important in the 
production of an inhibitory agent. A BGC contains genes that are involved in the precursor 
biosynthesis, tailoring steps, gene regulation and resistance and transport of the antibiotic 
(Adegboye and Babalola, 2012; Figure 1.2). The antibiotic backbone can be modified by a 
number of tailoring steps such as chlorination, glycosylation, methylation and others. Then, 
there are many regulatory genes in the cluster, overexpressing positive regulators and deleting 
repressor genes which may contribute to increase antibiotic production. Resistance genes are 
used to protect the organism from suicide and finally transport genes are used to take the 
antibiotic out of the cell. 
 
 
Figure 1. 2 Biosynthetic Gene Cluster 
Scheme of a biosynthetic Gene Cluster. 
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In these mega-enzymatic complexes, each gene encodes certain modules and each module is 
divided into domains. The actions of enzymes in the domains will lead to the activation and 
attachment of extender unit. The complexity in secondary metabolites biosynthesis depends 
on variations in the three processes. 
 
1.4.1. Polyketides 
Many secondary metabolites have been produced as polyketides and used as antibiotics 
(erythromycin, tetracycline), immunosuppressant (rapamycin) and antitumor agents 
(doxorubicin). Spore pigments have been also been known to be synthesized by polyketide 
synthases (Davis and Chater, 1990). Depending on the construction of the domains, PKSs are 
grouped into three types which can be modular (multifunctional proteins) known as Type I 
PKS (T1PKS) or iterative (small monofunctional repetitive proteins) and these are identified 
as Type I, II and III PKSs (T1PKS, T2PKS, T3PKS; Sattely et al., 2008). The biosynthesis of 
polyketides is very similar to the biosynthesis of fatty acids in that the acetyl and malonyl are 
condensed to give a long carbon chain under the action of the polyketide synthase (PKS; Figure 
1.3). For this to happen three proteins are required ketosynthase (KS), acyltransferase (AT) 
and acyl carrier protein (ACP) (Böhm et al., 1998). The main difference between the two 
biosynthetic routes is that the polyketides use a variety of carbohydrates units as starter units 
and therefore leading to compounds with different structures and chemical functions (Revill et 
al., 1996). The biosynthesis begins with acyltransferase (AT) which recognizes a suitable 
substrate and transfers it to ACP, once the substrate is attached to the ACP the formation of C-
C between the synthesized precursor and growing polyketide chain is catalysed by 
ketosynthase (KS; Bibb et al., 1989). Several modifications take place during assembly of the 
long chain governed by other enzymes such as ketoreductase (KR), dehydratase (DH), enoyl 
reductase (ER), cyclase (CYC) and aromatase (ARO; Zhan, 2009). PKS choose among the 
different modifications in each step of elongation which results in greater variation if the final 
product. In addition, PKS requires additional proteins involved in chain initiation and 
termination. AT and ACP are responsible for chain initiation while thioterase (TA) is required 
for chain termination by catalyzing the excretion of the polyketide chain from the enzyme, this 
is usually associated with cyclization (Keating and Walsh, 1999). The release of the 
synthesized polyketide backbone is followed by modifications by other  tailoring enzymes such 





Figure 1. 3 Backbone of Polyketides 
Polyketide backbone assembly. Adapted from Hertweck, 2009. 
 
1.4.2. Non-ribosomal Peptides  
Peptide BGCs are made of a large family of compounds with variety of chemical 
structure and biological activity. The peptide compounds can be synthesized by large 
multienzyme complexes (NRPSs) or by the classical ribosomal pathways (lantibiotics) 
(Widdick et al., 2003). Peptide compounds synthesized by non-ribosomal peptide synthetases 
(NRPSs) are composed of proteogenic (natural) and non-proteogenic (unnatural) amino acids 
leading to distinct and diverse peptide structures (Sieber and Marahiel, 2005). The synthesis 
of non-ribosomal peptide can take place with a single NRPS which often happens in fungi or 
by several NRPS proteins as it is the case in most bacteria (Finking and Marahiel, 2004) 
resembling the synthesis of T1PKS in which the proteins are attached by interpolypeptide 
linkers. NRPSs require 3 proteins acting as core domains: adenylation domain (A) which 
selects distinct amino acid and activates it into acyl adenylate using ATP, this amino acid is 
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then transported to peptidyl carrier protein (PCP) into which it hold the activated protein 
followed by the c-domain catalysing the formation of C-C bond (Figure 1.4; Keating et al., 
2000). NRPSs are made of modules, each one is responsible for the recognition and 
incorporation of one amino acid into the extender polypeptide chain (Marahiel, 1997). In 
addition to the core domains, the NRPS polypeptide chain have tailoring enzymes that are 
either essential in the NRPS and act in cis or separate enzymes that act in trans along the way 
to the final NRPS product (Finking and Marahiel, 2004).  The two most common modifications 
in the NRPS polypeptide chain are: 1- epimerisation (E) in which the cis-acting E-domain 
converts L-amino acids attached to PCP domain into D-isomers before transferring it to the 
next module and 2- methyltransferase (MT) domains responsible for the N-methylation of the 
NRPS residues  (Walsh, 2016). 
The module for the initiation differs from the termination in that it does not contain C-
domain and the last domain of the termination module is usually a thioesterase (TE) domain 





Figure 1. 4 NRPS modular organization 
Modules are divided into core domains which are: adenylation (A-domain), peptidyl carrier 






1.4.3. Hybrid PKS-NRPS 
Hybrid PKS-NRPS are secondary metabolites that are produced as a result of the fusion 
of PKSs and NRPSs together. These hybrid assembly lines make complex polyketide-amino 
acid-peptide hybrids that use acyl and aminoacyl building blocks in their final products. An 
example of a hybrid BGC is the immunosuppressant ascomycin (FK520) which consists of 11 
PKS modules spread on 3 proteins (FkbB, FkbC, FbkA) and one NRPS on FkbP protein (Gatto 
et al., 2005). Bleomycin (anticancer compound), another example, consists of ten NRPS 
modules and one PKS module. The biochemistry of the PKS and NRPS proteins in the hybrid 
seem to be similar to the non-hybrid molecules (Du et al., 2014); then how do these two 
enzymes interact to produce a hybrid molecule? The PKS-NRPS hybrid system can have 4 
different approaches (Figure 1.5): 1- tethered hybrid modular type where both the PKS and 
NRPS modules are found in the same polypeptide, 2- separate hybrid modular type where the 
PKS and NRPS are found as separate units. 3- Partially stand-alone hybrids use non-modular 
NRPS proteins with modular PKS system and 4- Stand-alone hybrids where the PKS and 
NRPS enzymes exist as individual proteins.  
In the tethered hybrid modular type, PKS-NRPS are formed by modules that are located 
in the same polypeptide. For example, leinamycin is an anticancer drug produced from S. 
atroolivaceus which consists of two NRPS modules and six PKS modules (Pan et al., 2017; 
Figure 1.5 A). One example of the separate hybrid modular approach is the biosynthesis of 
myxobacterial epothilons (Julien et al., 2000) where it consists of nine PKS modules that are 
divided over 5 proteins EpoA, EpoC, EpoD, EpoE and EpoF and one NRPS found as a separate 
protein EpoB (Figure 1.5B). In the third approach, partially stand-alone hybrids, the 
biosynthetic machinery involves type II NRPS (a dissociated NRPS) system with a modular 
PKS. The type II NRPS contains an A-domain and CP-domain and it makes an amino acid as 
an extender unit for the modular PKS. The generated aminoacyl unit moves from the CP 
domain of the type II NRPS to the CP/KS domain of the modular PKS. The modular PKS is 
not covalently bonded to the CP domain of the type II NPRST. The stand-alone AT domain 
recognizes the acyl building block and facilitates its transfer from the stand-alone CP to the 
fixed CP domain of the PKS module in the vicenistatin biosynthesis (Shinohara et al., 2011, 
Figure 1.5C). Finally, andrimid biosynthesis is an example of the fully stand-alone approach 
where the assembly line is very fragmented with a stand-alone transglutaminase and type II 
PKS and Type II NRPS (Figure 1.5D). Andrimid synthetase contain 11 proteins, none of the 
proteins have more than three domains (Jin et al., 2006). All the chain elongation happens 
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between intermediates targeted to different proteins because none of the proteins have more 
than one T domain. AdmA is a stand-alone CP in the type II PKS system and AdmI is a stand-
alone in the type II NRPS system. In the condensation reaction, the stand-alone 
transglutaminase (AdmF) recognizes and uses an acyl unit from AdmA and an aminoacyl unit 
from AdmI (Miyanaga et al., 2018). 
 
1.4.4. Ribosomally Synthesized and Post-translationally Modified Peptides 
Genome sequencing have led to the identification of ribosomally synthesized and post-
translationally modified peptides (RiPPs), it is a large group of natural products with many 
unique chemical structures and variety of biological activities. The biosynthesis of RiPPs starts 
with a precursor peptide containing a core peptide connected to a leader peptide, a follower 
peptide or both which aids biosynthetic enzymes for the post-translational modification (PTM) 
on the core peptide. After the modification of the core peptide, the leader and/or follower 
peptides are removed by proteases leading to the final product. Due to their ribosomal origin, 
RiPPs chemical structure can be easier to predict than other natural products making them 
more appealing for genome driven discoveries of natural products.  Some RiPPs such as 
lantipeptide duramycin to fight cystic fibrosis (Zeitlin et al., 2004) and labyrinthopeptin A2 for 
neuropathic treatment (Teichert and Olivera, 2010) progressed into clinical trials and 








Figure 1. 5 Types of PKS-NRPS hybrids 
PKS-NRPS hybrids can be classified into 4 types according to their biosynthetic lines. Tethered 
hybrid modular type (A), separate hybrid modular type (B), partially stand-alone type (C) and fully 
stand-alone type (D). PKS and NRPS are shown as pink and blue colours, respectively. 
Transglutaminase is shown in green colour and type II FAS AT in grey circle. Abbreviations: Cdd: 
C-terminal docking domain; CLF: chain-length factor; Cy: cyclization; DH: dehydratase; E: 
epimerase; ER: enoylreductase; KR: ketoreductase; KSº: ketosynthase-like transacylase; KSy: 
ketosynthase-like decarboxylase; MT: methyltransferase; Ndd: N-terminal docking domain; Ox: 
oxidase; TE: thioesterase; TG: transglutaminase Docking domains are shown as small circles. 
Docking domains are shown as small circles with red colour for class II docking domains, orange 
for class II docking domains, white for EpoB-Cdd/EpoC-Ndd-type docking elements, blue for 












Terpenes are the most diverse natural compounds discovered with more than 65,000 
different compounds (Jansen and Shenvi, 2014) with a variety of biological functions such as 
signaling molecules, antibiotics, odors or pigments. Terpenes are composed of two or more C5 
isoprene classified on the basis of the number of the isoprene units. Terpenoids are derivatives 
of terpenes which involves the addition or removal of the methyl groups or the addition of an 
oxygen.  
The biosynthesis of terpenes falls into three stages: 1- formation of isopentenyl 
diphosphate (IPP), 2- condensation of IPP and 3- cyclization and modification of the linear 
isoprenoids that are synthesized (Takahashi and Koyama, 2006). The IPP can be made either 
by the acetyl-CoA using acetate/mevalonate (MVA) pathway or the pyruvate and 
glyceraldehyde 3-phosphare using nonmevalonate or methyl-D-erythriol-4 phosphate (MEP) 
pathway (Rohmer et al. 1993). Most of Streptomyces use the MEP pathway (Dairi, 2005). 
Geosmin is an earthy smelling terpene and is the most commonly produced in Streptomyces. 
Another example is albaflavenone isolated from S. albidoflavus with an antibacterial activity 
(Zhao et al., 2008).  
 
1.4.6. Aminoglycosides 
Aminoglycosides are antibacterial drugs produced by actinobacteria. The first 
antibiotic produced by this family was streptomycin isolated from Streptomyces griseus and 
used for tuberculosis treatment (Wehmeier and Piepersber, 2009). Neomycin, kanamycin and 
gentamicin are other examples of aminoglycoside antibiotics. The name of the 
aminoglycosides is based on the structure of the antibiotics which involves an amino group 
attached to glycosides. The biosynthesis of aminoglycosides starts with monofunctional 
enzymes in which each activates one step in the pathway.  
 All aminoglycosides have similar structures with cyclitols as the core components and 
different sugars such as deoxysugars and aminosugars (Kudo and Eguchi, 2009). They bind to 





 Regulation of Secondary Metabolites  
Environmental stresses, especially nutrient depletion, along with primary metabolic 
responses leads to antibiotic production in Streptomyces (Martín and Liras, 2010). Therefore, 
the capability of Streptomyces to produce secondary metabolites depends on primary metabolic 
changes and the presence of precursors and nutrients required for their production (van Wezel 
and McDowall, 2011). The genes responsible for the biosynthesis of secondary metabolites are 
clustered on the chromosome or on the plasmid in Streptomyces. These clusters are usually 
large (about tens of kilobases) and have numerous operons (Chater, 1985). Most of the genes 
in the cluster code for enzymes that catalyse amino acids as building blocks leading to the 
production of the secondary metabolites (Niu and Tan, 2013). Genomic sequencing has 
allowed to study secondary metabolites biosynthesis at the molecular level, this has shed light 
on the complex development of the association of secondary metabolites with morphological 
differentiation. Most genomes contain more than 15 biosynthetic gene clusters for secondary 
metabolites but many of these metabolites are undetected under lab culturing conditions. 
Therefore, to identify these clusters we need to find ways of activating their expression by 
studying their environmental niches and regulatory mechanisms (van Wezel and McDowall, 
2011; Medema and Fischbach, 2015). The production of secondary metabolites is determined 
by many physiological and environmental factors such as nutrient depletion or the existence 
of signalling molecules. Most of the Streptomyces that have secondary metabolism are located 
in competitive and nutrient depleted environments, where the bacteria may produce inhibitory 
agents such as antibiotics to kill surrounding competitors (Stubbendieck and Straight, 2016). 
In Streptomyces, antibiotic production is governed by many regulatory proteins (Bibb, 
2005). Cluster-situated regulators (CSRs) have an effect on the levels of antibiotic production 
by controlling neighbouring gene transcription within a biosynthetic gene cluster (Liu et al., 
2013). There are other regulators that are functional at higher levels, such as pleiotropic 
regulators which are found outside the BGCs and effect production of multiple antibiotics and 
morphological development (Wei et al., 2018), and global regulators which are found in 
various locations on the chromosome and control CSR genes and central metabolic genes (Liu 
et al., 2013). Many of the global and pleiotropic regulators send signals from changes in the 
environment or cellular physiology to CSR genes. Gamma butyrolactone (GBL) is a signalling 
molecule that was identified in many Streptomyces species which act by binding receptor 
proteins to activate CSRs (Nodwell, 2014). 
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Studies have shown that Streptomyces have cryptic pathways with unexpressed BGCs and 
that it is crucial to discover new methods to activate these pathways (Li and Tan, 2017). These 
methods include optimization of culture and fermentation conditions, co-culturing to activate 
silent gene clusters, genomic sequencing to identify novel compounds, and activation of silent 
genes by inducing signalling molecules such as Ƴ-butyrolactone A-factor or with the amino 
sugar N-acetylglucosamine (GlcNAc) as a physiological signal. For example, In Streptomyces 
griseus A-factor regulates many genes that are involved in morphological differentiation and 
secondary metabolism (Demain, 1998). A-factor induces many proteins that control the 
production of Streptomycin and its deletion leads to loss of transcription of the Streptomycin 
gene cluster (Mansouri et al., 1989). Many Streptomyces produce A-factor or related γ-
butyrolactones that induce the production of other antibiotics (Gräfe et al., 1984). Another 
group of important regulators is GntR-family such as DasR (GntR-like repressor) which has 
been shown to control gene expression in secondary metabolism and morphogenesis in 
response to environmental conditions (Aigle and Corre, 2012). DasR changes the levels of 
gene expression in secondary metabolites and antibiotic production depending on the levels of 
chitin monomer N-acetylglucosamine (GlcNAc) in the environment (Martín et al., 2011). 
 
1.5.1. Culturing Conditions  
Culturing conditions for primary metabolites, which are involved in growth and 
division, are different than conditions required for secondary metabolites. Therefore, changes 
in culturing conditions may increase or decrease secondary metabolite production. The effect 
of carbon, nitrogen, phosphate, light, temperature, oxygen concentration and pH play 
important roles in the production of secondary metabolites. These different environmental 
factors can also be different from one species to another depending on the source of habitat 
where the organism was isolated from.  
The carbon source has been identified to play a major part in the production of both 
primary and secondary metabolites. The carbon source to be used by Streptomyces at the 
molecular level can either inhibit genetic activation or repression (Uguru et al., 2005). Gene 
inhibition by a carbon source is known as carbon catabolic repression (CCR)  (Hodgson, 2000) 
and this event has been observed by glucose in organisms such as E. coli and Salmonella 
(Deutscher, 2008) but few studies have been done in Streptomyces. Yet, there are many 
secondary metabolites that have been repressed by the presence of carbon source, for instance 
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glucose represses the activation of biosynthetic enzymes in the production of aminoglycoside 
antibiotics (Demain, 1989). In nature, nutrients are found in a variety of forms from simple to 
complex and Streptomyces have the capability of producing extracellular hydrolytic enzymes 
to degrade complex polymers (McCarthy and Williams, 1992). In recent studies, N-
acetylglucosamine (GlcNAc) has been found to increase the production of actinorhodin 
antibiotic in Streptomyces coelicolor, GlcNAc increased antibiotic production in poor 
conditions and inhibited production in rich conditions (Świątek et al., 2012). This phenomenon 
is not observed for all species, for example GlcNAc has no effect on Tetracycline antibiotic 
production in S. rimosus (Rigali et al., 2008). The source of GlcNAc in nature could be as 
peptidoglycan in the bacteria’s cell wall under poor conditions or as chitin under rich 
conditions (Sanchez et al., 2010).  
Studies have shown that nitrogen present in simple organic and inorganic forms may 
decrease lincomycin antibiotic production in an industrial strain of S. lincolnensis (Young et 
al., 1985). However, using complex nitrogen sources such as soya bean, yeast extract, peptone 
and casein increased secondary metabolites production in S. albidoflavus (Narayana and 
Vijayalakshmi, 2008). Factors such as incubation period, temperature and pH have also been 
found to influence the production of secondary metabolites. Most studies based on different 
Streptomyces species conclude that exponential growth is observed after 4-7 days of incubation 
and stationary phase starts at about 10 days. Therefore, secondary metabolism is usually 
observed during the end or near the stationary phase of growth; the ultimate temperature 
observed for Streptomyces growth and secondary metabolites production is 28-30 °C with a 
neutral pH. Minerals such as MgCl2 and KNO3 seem to have positive effect on some 
Streptomyces species while ZnCl2 and MnSO4 had a negative effect (Bundale et al., 2015).  
Phosphate is another signal molecule that affects morphological differentiation and 
secondary metabolism.  Inorganic phosphate (Pi) is the preferred sources of phosphorous in 
bacteria and it is carried to the cell either by high affinity phosphate transporter (Pst) or low 
affinity inorganic transporter (Pit) (Santos-Beneit et al., 2008). Organic phosphate compounds 
(sugar phosphatase and phospholipids) are hydrolysed to phosphatases and phosphodiesterases 
by Streptomyces before they enter the cell (Apel et al., 2007). Phosphate has been identified as 
a repressor for the biosynthesis of some secondary metabolites. The level of the extracellular 
phosphate is influenced by the PhoR/PhoP two component system. When Pi is under scarce 
conditions PhoR, which is a membrane bound phosphate sensor protein, is autophosphorylated 
leading to the activation of PhoP response regulator. Phop expresses genes that are involved 
in the biosynthesis of secondary metabolites (Santos-Beneit et al., 2008). 
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In summary, the culturing conditions for each strain of Streptomyces has to be 
optimized as each species may require different carbon, nitrogen and mineral sources for 
positive initiation and production of secondary metabolites. 
1.5.2. Co-culturing with Other Organism  
Co-culturing is another approach that can be used to increase the production of known 
antibiotics, produce novel secondary metabolites or increase the yield of secondary metabolites 
(Pettit, 2009). In nature organisms exist together which leads to interspecies interaction and 
initiation of bioactive compound production (Oh, et al., 2005). These interspecies interactions 
may induce production of secondary metabolites which otherwise would not be detected in the 
culture. In the laboratory, organisms can be co-cultured together to activate production of 
secondary metabolites, for example co-culturing Streptomyces sp. with mycolic acid-
containing bacteria has led to the production of alchivemycin A antibiotic (Onaka et al., 2011). 
Cellular physiology and signalling molecules are highly affected when two organisms are co-
cultured together (Hogan et al., 2004). Studies of co-culturing S. coelicolor and B. subtilis, 
spore forming soil bacteria, have shown that aerial hyphae were inhibited in S. coelicolor as a 
result of the production of surfactant lipopeptide surfactin by B. subtilis (Straight et al., 2006). 
This surfactant which is required for aerial development in B. subtilis has antagonized the 
activity of surfactant SapB, needed for aerial hyphae production in S. coelicolor (Kodani et al., 
2004), causing loss of aerial structures production. Co-culturing experiments of S. 
tenjimariensis, which produces istamycin antibiotic, with other organisms has led to a 2-fold 
increase in the production of the antibiotic (Slattery et al., 2001). Undecylprodigiosin is an 
anticancer compound produced by S. coelicolor, a 6-fold increase in the production of this 
compound was observed when S. coelicolor was co-cultured with E.coli (Luti and Mavituna, 
2011). An increase in this compound was also found when heat-inactivated Bacillus subtilis 
was added to the S. coelicolor culture (Luti and Mavituna, 2011). Competition that happens in 
co-culturing leading to the production of bioactive compounds may not take place in a 
monoculture.  
 
1.5.3. Effect of Signalling Molecules 
An important factor that has been found to effect bioactive metabolites production are 
signalling molecules such as γ-butyrolactones (GBL) as they are permeable through the cell 
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membrane of Streptomyces which facilitates their entrance to the cell. They bind to receptor 
proteins which act as repressors for antibiotic synthesis. This interaction results in structural 
change in the repressor protein hindering it from binding to the targeted DNA of the antibiotic 
cluster (Takano, 2006), leading to the synthesis of the antibiotic. A-factor is the first GBL to 
be explored in Streptomyces and found to be associated with the production of Streptomycin 
antibiotic and sporulation in S. griseus (Khokhlov et al., 1967). Cultivation with γ-
butyrolactones may lead to signal-receptor binding and production of otherwise repressed 
secondary metabolites. 
Searching for secondary metabolites from natural habitats is still of great interest, even 
with the emergence of the synthesis of synthetic antibiotics, as it is a rich and unlimited source 
for finding new antimicrobial agents with new structures and chemical properties (Baltz, 
2006). The aims of this project are to explore the isolation of novel antimicrobial and/or 
antitumor bioactive compounds from terrestrial and/or marine habitats. Potential Streptomyces 
isolates showing inhibitory activity against Gram-positive, Gram-negative, yeast and fungus 
will be characterized physiologically, morphologically and molecularly. Cytotoxicity of these 
strains on cancer cells will be assessed. The effects of elicitation experiments will be studied 
to observe any novel production of secondary metabolites or increase the yield of existing ones. 
Genomic sequencing and organic extraction will be performed to isolate the presence of any 
bioactive compounds. 
 
1.5.4. Effect of N-acetylglucosamine (GlcNAc) 
Terrestrial Streptomyces can respond to changes in the environment and contain sigma 
factors which regulate gene expression during vegetative growth and sporulation in poor 
nutrient conditions and they, also, have a two-component system that makes them capable of 
sensing and responding to environmental stimuli (Martín and Liras, 2010). In terrestrial 
habitats, Streptomyces evolved about 400 million years ago with the main role of solubilizing 
cell walls of fungi, insects and plants (Chater et al., 2010). There is a great partnership between 
Streptomyces and fungi with fungal cell walls being an important source of nutrition. Chitin is 
a major component of fungal cell walls and the most dominant, Streptomyces produce 
hydrolytic enzyme chitinase to degrade chitin in the soil (Nazari et al., 2011). N-
acetylglucosamine (GlcNAc) is an amino sugar that has many roles in cell signalling pathways 
that is related to virulence in microbes. GlcNAc is an important component of the bacterial cell 
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wall peptidoglycan and a monomer of chitin. It is the preferred source of carbon and nitrogen 
in Streptomyces and acts as a signalling molecule in the bacteria (Rigali et al., 2006). A change 
in the morphological differentiation and antibiotic production has been observed when there is 
an increase in the concentration of GlcNAc around the Streptomyces colonies. GlcNAc has 
been observed to induce development and antibiotic production in famine (poor nutritional 
conditions) while inhibition occurs in feast (high nutritional conditions) (Rigali et al., 2008). 
This observation of antibiotic inhibition on rich nutrient medium is common but not universal 
in the Streptomyces (Colson et al., 2008). 
S. coelicolor has been well studied for the effect of GlcNAc on nutritional conditions, 
studies showed that the master regulator DasR, GntR family repressor, plays a crucial role in 
metabolism and transport of GlcNAc (Rigali et al., 2004). The binding affinity of DasR is 
regulated by ligands produced from GlcNAc-6P and GlcN-6P. GlcN-6P is an intermediate of 
carbon and nitrogen metabolism and cell wall synthesis and also acts as an effector on DasR 
antibiotic production system; therefore, it plays an important role between primary and 
secondary metabolism (van der Heul et al., 2018) (Figure 1.6). DNA-binding capability of 
DasR depends on environmental changes. In minimal medium, high concentration of GlcNAc 
leads to inactivation of DasR (inhibiting the repressing action of DasR) and its targets which 
results in increased antibiotic production while rich nutrient media leads to decrease in GlcNAc 
leading to inhibition of antibiotic production (Rigali et al., 2006). Therefore, addition of 
GlcNAc to a culture media may induce production of silent BGCs (Rigali et al., 2008). This 








Figure 1. 6 DasR regulatory cascade by S. coelicolor 
GlcNAc is transported to the cell by phosphotransferase system (PTS) where it is 
phosphorylated to GlcNAc-6P. NagA deacetylates GlcNAc-6P to glucosamine-6-P (GlcN-
6P) which can be used for nitrogen metabolism, cell wall synthesis or glycolysis. Adapted 
from van der Heul et al., 2018. 
 
 Genomic Sequencing 
The rapid increase in the sequencing technologies and easy access to bacterial genomes 
has brought back the focus on antibiotic producing organisms. Genetic data of these organisms, 
especially for Streptomyces, are showing that their metabolic potential has been 
underestimated (Corre and Challis, 2009). Genomics, bioinformatics, synthetic biology and 
mass spectrometry has allowed special attention to be given to underexplored organisms with 
secondary metabolism capabilities (Brady et al., 2009). The association of secondary 
metabolites to the genes that produce them has allowed the discovery of novel molecules 
through genome sequencing data (Bergmann et al., 2007). Genome sequences have uncovered 
many gene clusters that encode for bioactive molecules. 
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Genome sequencing uses shotgun sequencing strategy where the DNA is cut into small 
fragments which are separately sequenced. Computer algorithms are used to assemble the 
generated reads into longer regions of sequence known as “contigs” and this process is called 
de novo assembly. For appropriate assembly there should be enough overlap between the reads. 




Figure 1. 7 De novo assembly of Genomic sequencing 
In Genomic sequencing DNA is fragmented into small pieces that are sequenced separately 
which are known as sequence reads. Overlaps between reads are identified and assembled 
into contigs and then they are assembled into scaffolds and a consensus sequence is 
generated. Adapted from Seemann, Melbourne University 
 
 
Genome mining technique has become a very popular and encouraging with the 
improvement of whole genome sequencing methods and the availability of the data. The 
genome sequence is analysed for the identification of genes encoding for enzymes that are 
associated in the production of secondary metabolites. S. coelicolor sequencing has uncovered 
the presence of cryptic BGCs (Bentley et al., 2002) with more than 20 BGCs identifying a 
variety of secondary metabolites (Challis and Hopwood, 2003). A number of actinobacterial 
genomes may carry up to 50 BGCs but most of them are silent under laboratory conditions or 
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produced in small amounts (Cao et al., 2016). This has promoted the sequencing and analysis 
of many species to identify new BGCs and how to develop ways to enhance or induces 
production of natural products in the lab (Bibb, 2005; Ling et al., 2015; Scheffler et al., 2013). 
There are a variety of bioinformatics tools that can be used to identify BGCs such as 
AntiSMASH and PRISM. These databases rely on known or conserved biosynthetic genes; 
although secondary metabolites are very diverse yet many of the biosynthetic intermediates 
are conserved (Ziemert et al., 2016). AntiSMASH does not only identify BGCs but also 
compares submitted sequences to massive databases of other organisms and MIBiG database 
to identify similar pathways (Medema et al., 2015). AntiSMASH and PRISM software are also 
capable of predicting the structure of the polyketide and peptide enzymes. Clusters identified 
as inactive are known as cryptic or silent clusters.  
One of the main reasons why Streptomyces are not able to produce the secondary 
metabolites they are capable of producing in laboratory conditions is due to the tightly 
regulated metabolic pathways (van Wezel and McDowall, 2011). In Streptomyces, the genes 
required for production of natural products are clustered together. Regulatory elements and 
self-resistance genes are usually co-located with the biosynthetic genes (Bentley et al., 2002). 
These silent genes are not expressed in the lab conditions or they are expressed but they 
have some physio-chemical properties that are not allowing their identification. If we have 
some information about some features of the structure and their physio-chemical properties, 
then analytical techniques can be utilized to focus on identifying these metabolites with these 
specific characteristics. Conserved regions such as PKSs and NRPSs have distinct peptide 
sequences. Acetyl transferase (AT) domain in PKSs and adenylation (A) domain in NRPSs 
have highly conserved sequences and it is possible to estimate substrate specificity from the 
amino acid sequence only. This was used in the identification of coelichin siderophore in S. 
coelicolor (Lautru et al., 2005) (Figure 1.8A). 
  Most of the bioinformatics tools related to analysis of genomic sequencing data can 
mainly identify the enzymes involved in a biosynthetic cluster and in some cases the structure. 
Thus, in order to link natural products to a specific pathway we will need to perform genetic 
manipulation. In cases where it is not possible to predict the structure then universal approach 
has to be taken. One of these approaches is to express the BGC of interest into a heterologous 
host, secondary metabolites produced by the wild type and non-producing mutant are 
compared to discover novel secondary metabolites and associate their biosynthesis to the BGC 
introduced in the host organism (Figure 1.8B). This approach was used in the discovery of 2-
alkyl-4-hydroxymethylfuran-3-carboxylic acids (AHFCA) compounds from S. coelicolor 
 
24 
(Corre et al., 2008). M1146 and M1152 are heterologous hosts of S. coelicolor where large 
gene clusters such as actinorhodin, coelimycin and calcium-dependent antibiotic were deleted. 
Another approach is to knock out the gene of interest and replace it by a resistant marker 
(Figure 1.8C). A gene from the BGC is inactivated, then extracts from both the wild type and 
mutant are compared using analytical methods such as liquid chromatography-mass 
spectrometry (LC-MS). Natural products found in the wild type but not in the mutant are 
correlated to the products of the silent cluster. Mass spectrometry is then used to characterize 
this portion. This approach was used in the identification of germicidins (Song et al., 2006). 
Overexpression of activator and inactivation of repressors is another model that can be used 
for the production of silent BGCs. Normally, regulatory genes influence the production of 
metabolites in clusters (Bibb, 2005; van Wezel and McDowall, 2011). In S. coelicolor, actII-
orf4 and red are transcriptional activators that are located within the gene cluster for the 
biosynthesis of actinorhodin and streptorubin B respectively (Aigle and Corre, 2012; O'Rourke 
et al., 2009). Hence, regulatory genes in a targeted biosynthetic pathway may be used to 
activate silent pathways (Aigle and Corre, 2012; Laureti et al., 2011) (1.8D and E). An example 
of this model is overexpression of the transcriptional activator samR0484 in S. ambofaciens 
by positioning it under the ermE promoter which led to the discovery of stambomycins (51 














Figure 1. 8 Genomic Mining Methods 
A variety of strategies can be used for the discovery of secondary metabolites. Some of the strategies are: (A) bioinformatics tools used to predict 
biosynthetic genes by BGCs such as antiSMASH, (B) expressing genes in host strains, (C) knocking out genes to predict their roles as biosynthetic 
genes, (D) identify activators to overexpress the BGC of interest and (E) identify repressors to be deleted to increase the expression of a BGC 
 
26 
Heterologous expression is a promising technique to identify unknown BGCs. The 
advances in synthetic biology along with CRISPR/Cas techniques have allowed us to 
successfully clone and remodel BGCs. Heterologous expression is affected by the position of 
the BGC to be integrated, copy number, regulatory elements and promoters (Huo et al., 2019). 
About 30% of the BGCs taken from a native streptomycetes genome will be expressed in 
another Streptomyces host, this “refactoring” of BGCs allows the replacement of the native 
regulatory elements with synthetic regulatory elements for the successful heterologous 
expression of the secondary metabolite (Myronovsky and Luzhetskyy, 2019). Most of the 
BGCs in Streptomyces are regulated at the transcription level. Therefore, strong promoters are 
required to ensure expression of the biosynthetic genes, ermEP1-semisynthetic promoters were 
used to activate the silent lazarimide BGC leading to the identification of lazarimide A, B and 
C with high anti-cancer activity (Siegl et al., 2013). Another important factor in heterologous 
expression is the host. Streptomyces hosts are the most prominent to use as they contain the 
appropriate precursors and they provide proper environment for the successful expression of 
the refactored BGC (Gomez-Escribano and Bibb, 2014). Optimally, expression of active BGCs 
would be in the original producer organisms but for silent BGCs an alternative host may 
provide regulatory and biosynthetic elements for better heterologous expression (Myronovsky 
and Luzhetskyy, 2019). Nowadays, the most commonly used hosts for the production of 
secondary metabolites are S. avertimitis, S. coelicolor, S. albus, and S. lividans (Huo et al., 
2019). Although, the type of host is highly important for heterologous expression yet it could 
produce low yields as a result of the supply of precursors, availability of cofactors or 
differentiation of metabolic and transcriptional regulation (Huo et al., 2019). Heterologous 
expression has been well-developed for silent biosynthetic genes but these hosts require 
improvement in their characteristics in order to increase cluster expression (Myronovsky and 
Luzhetskyy, 2019).  
 
 Liquid Extraction Surface Analysis 
Genomics development has revealed that many organisms are capable of producing many 
secondary metabolites. Many of these secondary metabolites are only predicted by 
bioinformatics analysis and are not produced under standard laboratory conditions or are 
produced under very low concentrations to be detected. In section 1.6, we have shown that 
genetic manipulations can be used to identify these silent secondary metabolites. 
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Metabolomics plays a key role in identifying metabolites at the metabolic level by measuring 
many low molecular weight compounds (Berg et al., 2013). Analytical methods are the most 
commonly used in secondary metabolites studies, you can cluster microbial strains based on 
the metabolites they produce (Hou et al., 2012). Mass spectrometry has allowed us to identify 
novel compounds when biosynthetic gene clusters are activated by genetic manipulation, 
different growth condition, co-culturing with other organisms or induced with other external 
factors such as γ-butyrolactone as a signalling molecule.  
A direct surface sampling technique known as liquid extraction surface analysis (LESA; 
Kertesz and Berkel, 2010) mass spectrometry is a new significant technique for the analysis of 
many biological samples such as lipids (Griffiths et al., 2013), proteins (Kocurek et al., 2017) 
and drugs (Eikel et al., 2011). Extraction of analytes from the surface takes place through liquid 
microjunction by using TriVersa NanoMate automated pipette tip system (Kertesz and Van 
Berkel, 2010). The LESA technique is based on the solvent ejected by a pipette tip to the 
surface of the sample (colonies) where it stays for few seconds to form a liquid microinjection, 
then the analyte diffuses into the solvent and then the droplet is retrieved into the pipette tip 
where it is injected by nanoelectrospray ionization into the mass spectrometer (Figure 1.9). 
The main advantage of the LESA technique is the ability to analyse a variety of analytes from 
one location directly from the sample surface (in our case from the colonies) without advance 
preparation. The main drawback of the technique is the extraction of a variety of molecules 



















Figure 1. 9 Screening of Streptomyces isolates by LESA 
All Streptomyces isolates were cultured on ISP1 agar medium, ISP1 agar medium induced with 
0.7% GBL and ISP1 agar medium induced with 50 mM GlcNAc. Uninduced and induced 
bacterial colonies were screened by LESA-MS system and generated peaks were analyzed using 




 Project aims 
The aim of this project is to identify novel Streptomyces strains isolated from UAE 
terrestrial habitats with the ability to produce antimicrobial and antitumour agents. This will 
be achieved by studying the antibacterial antifungal and antitumour activity of the isolated 
strains followed by elicitation studies with B. subtilis lysate, γ-Butyrolactone and N-
acetylglucosamine. Finally, whole genome sequencing and metabolomics using the novel 
liquid extraction surface analysis will be applied to identify secondary metabolites. The 
principle aims to achieve the above were: 
 
1- Isolate Streptomyces from soil samples and test antimicrobial/antitumor inhibitory activity 
of the isolated Streptomyces strains and culture extracts. 
2- Physiological, biochemical and molecular characterization of the Streptomyces isolates. 
3- Optimization of cultivation parameters by elicitation to increase secondary metabolite 
production or produce novel secondary metabolites. 
4- Explore cytotoxic activity of the culture extracts against HeLa cancer cell line. 
5- Genomic sequencing of the Streptomyces strains to identify biosynthetic gene clusters 
(BGCs). 














2. Materials and Methods 
 General reagents, bacterial strains and culture media 
Genomic DNA extraction kit was purchased from Promega. All chemical reagents used 
including DAPI stain were purchased from Sigma-Aldrich (USA). Bacterial and cancer cells 
were purchased from American Type Culture Collection (Rockville, US). Strains used in this 
study are: Escherichia coli (ATCC ® 25922), Staphylococcus aureus (ATCC® 29213), Candida 
albicans (ATCC® 66027), Saccharomyces cerevisiae (ATCC® 2601) and Bacillus subtilis 
(ATCC® 6051) and human cervical adenocarcinoma cell line (HeLa). E. coli-ESBL (extended 
spectrum Beta-Lactamase) obtained from the microbiology lab at the University of Sharjah 
Hospital, Sharjah, UAE. 
Most forms of microbial media used in this study were purchased from HiMedia 
Laboratories (India) and prepared according to manufacturer’s recommendation unless 
mentioned otherwise. Luria Bertani Broth, Miller (LB, cat# M1245), Luria Bertani agar, Miller 
(cat# M1151), Starch casein agar (SCA, cat# M801), Mueller hinton agar (cat# M173), 
Oatmeal agar (cat# M397), Tryptone yeast extract (ISP1, cat# M356), Zobell marine agar (cat# 
M384),  Glycerol asparagine (ISP5, cat# M360), Yeast malt broth (cat# M425), Tryptone 
glucose yeast extract broth (cat# M952), Peptone yeast extract iron agar (ISP6, cat# M361), 
Tyrosine agar (ISP7, cat# M362) 
Dulbecco’s modified eagle medium (DMEM) was supplied from Sigma Aldrich (USA). 
Foetal bovine serum (FBS), penicillin-streptomycin and Trypsin-EDTA were purchased from 
Gibco (Life technologies, UK). 
 
 Sample collection and location 
2.2.1. Terrestrial sample collection 
Fifteen soil samples were collected from 8 cultivated central locations (Figure 2.1) 
namely Al Khawaneej, Al Mizhar, Al Warqa, Al Qusais, Oud Al Mateena, University of 
Sharjah Campus, Al Jurain and Al Dhaid. After removing the top 3 cm of soil, the samples 
were collected with a shovel down to a depth of about 10 cm (Figure 2.2) and placed in 
polystyrene bags. Samples were stored at 4°C prior to processing. The names of the samples 






Figure 2. 1 Locations of the Terrestrial Samples 





Figure 2. 2 Soil Sample Collection 





Table 2. 1 Sample Labeling 




Soil Sample ID Location GPS Coordinates 
CSK Al Khawaneej 25.22739, 55.517345 
CSM Al Mizhar 25.256970, 55.40414 
CSW Al Warqa 25.183040, 55.443815 
CSQ Al Qusais 25.264058, 55.398643 
CSO Oud Al Mateena 25.266124, 55.453377 
CSU University of Sharjah 25.287253, 55.480456 
CSG Al Gharayen 25.302647, 55.509504 




2.2.2. Marine sediment sample collection 
Seventeen marine samples, were collected from the coastline shore of the Arabian Gulf 
(Figure 2.3) from Ajman to Tarif (near the border of Saudi Arabia), samples were labelled 
according to names of collection location (Table 2.2). The samples were collected by removing 
some of the marine sediment upper layer with a shovel and then scooping a sample of the 
sediment with overlying water using a wide neck glass bottle and placing it in polystyrene bags 
at 4°C until processing time (van veen grab was not available for sample collection). Sample 
collection was done under the water for all samples except for Ras AlKhaima/Sha’am and 









Figure 2. 3 Maps of the aquatic sample collection locations 
Samples were collected from different locations along the coast of the Arabian Gulf starting 







Table 2. 2 Marine sample labeling 
The names of the samples were abbreviated according to sample’s location 
 
Marine Sample ID Location GPS Coordinates 
MSA Ajman 25.3946409, 55.4202767 
MSU Umm Al Quwain 25.317231, 55.5719047 
MSR1 Ras Al Khaima 25.6565362, 55.7468665 
MSR2 Ras Al Khaima 25.8508129, 55.9973148 
MSR3 Ras Al Khaima / Sha’am 26.0326448, 56.0837734 
MSR4 Ras Al Khaima / Sha’am 26.0405369, 56.0846891 
MSY1 Yas Island 24.5153439, 54.6053472 
MSY2 Yas Island 24.5162698, 54.6017886 
MSY3 Yas Island 24.5167566, 54.6004619 
MSY4 Yas Island 24.5128709, 54.5495888 
MSY5 Yas Island 24.5170577, 54.5374062 
MSY6 Yas Island 24.5181504, 54.527784 
MSH1 Hamim 54.3850158, 54.3850158 
MSH2 Hamim - 
MSD1 Dabiya 24.2783542, 54.1816004 
MSD2 Dabiya 24.3143852, 54.1224658 
MST1 Tarif 24.0653839, 53.8766946 




2.2.3. Sample treatment 
The terrestrial and marine samples were air dried in a chemical hood overnight to 
facilitate the isolation of Streptomyces. The samples were then heat treated by placing the 
samples in a water bath at 56 °C for 30 min to prevent the growth of vegetative cells (Saadoun 
et al., 1999). All samples were diluted up to 10-5 with sterile water for terrestrial samples and 





Table 2. 3 Artificial sea water recipe (adapted from Cold Spring Harbor Protocols) 
The quantities are for 1 L 
 
 










 Isolation of Streptomyces 
2.3.1. Culture conditions  
One gram of soil sample was suspended in 9 ml of either sterile water or sterile artificial 
sea water respectively. Each sample was serially diluted 10-1 to 10-5, 0.1 ml of the last three 
dilutions (10-3 to 10-5) were spread on Starch Casein Agar (SCA) plates made with sterile 
water. The plates were incubated at 28°C for 7-14 days and observed for the growth of 
Streptomyces colonies that were identified by their firm, chalky and rough textures. These 
colonies were picked and streak purified on SCA and oatmeal agar plates for morphological 
characterization and refrigerated as working stocks. Pure cultures were inoculated into 50 ml 
of Tryptone yeast extract medium (ISP1) and incubated at 28 °C for 7-10 days in a rotary 
shaker (125 rpm) before screening. 
 
2.3.2. Selective isolation of Streptomyces from marine sediment samples 
Streptomyces could not be isolated from marine sediment samples using the above 
standard method; therefore, samples were subjected to different pretreatment methods as 
follows: (1) Ten grams of marine sediment sample was suspended in 90 ml artificial sea water 
(ASW) incubated at room temperature for 1 hr in a shaker at 180 rpm; (2) 10 g of marine 
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sediment was suspended in 90 ml of ASW and enriched by shaking at 180 rpm for 14 days at 
RT; (3) 0.1 g of CaCO3 was added to 1g of marine sediment sample and incubated at 28 °C for 
7-14 days, then samples were serially diluted and spread on SCA and Zobell marine agar 
medium; (4) SCNA medium was constituted using artificial sea water (ASW) instead of de-
ionized water and (5) Decreasing ASW concentration to 25% and using it to constitute SCA.   
 
 Screening Streptomyces for antimicrobial activity 
2.4.1. Disk diffusion method 
Inhibitory activity of pure isolates recovered from terrestrial samples was assessed 
against E. coli and S. aureus by using the disk diffusion method (Kirby Bauer method; Bauer 
et al., 1966)) on Mueller Hinton agar medium. From the Streptomyces purified agar stocks 
(working stock), disks of 10 mm in size of Streptomyces’ colony mass were prepared by using 
sterile cork borers. The disks were transferred aseptically to Mueller Hinton agar plates spread 
with fresh overnight culture of the target microorganism with an OD between 0.02 and 0.05. 
Plates were incubated at 28 °C for 24 – 72 hrs and zones of inhibition were measured in mm 
(Figure 2.4). Strains that showed inhibitory effect against both E. coli and S. aureus were 








Figure 2. 4 Disk Diffusion Method Diagram 
Disks were cut from Streptomyces colony mass and placed on a bacterial lawn. After 
incubation at 28 °C for 24 hrs some isolates exhibited zones of inhibition (clearance of 
bacterial growth) around the disks while others did not have any inhibitory properties 
towards the tested organism and therefore no zone of inhibition was observed. 
 
2.4.2. Well diffusion method 
Well diffusion method was used to test antimicrobial activity of the filtrates against E. 
coli, S. aureus, C. albicans and S. cerevisiae. Spores from pure cultures were inoculated into 
50 ml of tryptone yeast extract medium (ISP1) and incubated at 28 °C for 7-14 days in a rotary 
shaker (125 rpm), mycelium and supernatant were separated by centrifugation at 4,000 rpm 
for 10 minutes. The filtrate was collected and filtered with 0.22 µm filters. A lawn culture of 
the target microorganism was spread on Mueller hinton agar plates, well of 5 mm in diameter 
were made with the end of a sterile pasteur pipette, the discs from the wells were removed and 
50 µl of the Streptomyces strains’ filtrates were added into the well (Figure 2.5). Antagonism 







Figure 2. 5 Well Diffusion Diagram 
Wells were made on mueller hinton agar plates inoculated with the tested organism using 
the end of sterile Pasteur pipette. Streptomyces organic extracts were added into the wells. 
Zones of inhibition were measured based on the diameter (d) in mm of the clearance of 
growth surrounding the well.  
 
 Physical and biochemical characterization 
Streptomyces isolates that produced microbial inhibition were characterized physically, 
biochemically and morphologically in reference to the International Streptomyces Project (ISP) 
(Shirling and Gottlieb, 1966) and Bergey’s Manual of Systematic Bacteriology (Locci, 1989). 
Physiological and biochemical tests included gram staining, carbon utilization, melanin 
synthesis and hydrogen sulphide production. 
2.5.1. Macroscopic and microscopic morphological characterization 
Morphological identification was based on the growth patterns of the isolates on 
oatmeal agar and starch casein agar (SCA). The colour of the aerial mycelium, substrate 
mycelium and soluble pigment production was observed by the naked eye. Bacterial smear of 
each isolate was prepared and gram stained to observe under the light microscope in order to 
assess spore chain morphology. 
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2.5.2. Melanin production 
Production of melanoid pigments were observed on peptone iron agar (ISP6) and 
Tyrosine agar (ISP7) agar slants streaked with the culture inoculum after 2 and 4 days of 
culturing. Inoculated slants were compared to uninoculated control. Formation of green to 
brown to black diffusible colours is considered as positive. 
 
2.5.3. Carbon source utilization 
Four carbon sources (inositol, L-Arabinose, xylose and sorbitol) were assessed. Ten 
percent solution (w/v) of each carbon solution was filter sterilized and added to basal mineral 
salts agar medium to make a final concentration of 1%. The mixture was poured into petri 
dishes and incubated at 4°C.  A washed inoculum was prepared by transferring 1 ml of turbid 
suspension of spores into 5 ml of ISP1 medium and incubated at 28°C for 48 hrs. After 
incubation, the mixture was vortexed for 30-60 seconds, the suspension was centrifuged at 
11,000 rpm for 10 minutes and resuspended in sterile 0.85% saline. The centrifugation and 
washing steps were repeated twice. Finally, 50 µl of the washed inoculum was used to streak 
the prepared carbon plates. Glucose was used as a positive control and no carbon source was 
negative control. 
 
2.5.4. Hydrogen sulphide production 
Peptone-iron agar slants were prepared as manufacturer’s instructions. The slants were 
streaked with culture inoculum of each isolate and observed after incubation at 28°C for 4 to 
15 hrs. Bluish-black coloration of the medium surrounding the colonies signifies production 
of hydrogen sulphide. Isolates that do not produce hydrogen sulphide will result in no change 
of the medium. 
 
 Preparation of organic extracts  
Streptomyces isolates’ cultures were grown in 25 ml of yeast tryptone extract medium 
(ISP1) for 21 days at 28°C. The cultures were centrifuged at 5,000 rpm for 10 minutes. The 
supernatant was filtered with 0.22 µM syringe filters. An equal amount of ethyl acetate 
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(EtOAc) was added to the filtered isolates. The mixture was allowed to shake for 30 minutes 
before adding it to a funnel to allow the separation of the two phases. The organic phase layer 
was evaporated to dryness in an oven at 50°C. The residue was then weighed and resuspended 
in 1-3 ml ddH2O (depending on the weight, if it is low or high) and filtered with 0.2 µM syringe 
filters. These organic extracts were used to assess the “Minimum Inhibitory Concentration” 
(MIC) on microbes and cytotoxicity on HeLa cells. 
 
 Minimum Inhibitory concentration (MIC) 
The minimum inhibitory concentration (MIC) for all isolates (organic extracts purified by 
ethyl acetate) was determined by resazurin-based turbidometric (TB) assay (Elshikh et al., 
2016). A 96 well microtiter plate was set up with 50 µl of mueller hinton broth added to all 
wells from column 2 to column 12, column 1 contained only 100 µl of mueller hinton as a 
control for sterility. The isolates were prepared by diluting the organic extracts of CSK1, 
CSK3, CSW2, CSU1, CSU2 and CSG1 in mueller hinton to 2x the top concentration required 
in the test (30 µg/µl) and the tested bacteria (E. coli, S. aureus, C. albicans, S. cerevisiae, B. 
subtilis and E. coli-ESBL) was standardized to optical density of 0.05 at 600 nm. A volume of 
50 µl of the 2x organic extract of the isolate was added to column 2, a twofold step dilution 
was performed up to column 11 with extracts concentration ranging from 30 to 0.12 µg/µl. The 
standardized bacterial suspension was added to columns 2 to 12 to a final volume of 100 µl. 
Column 12 contained only the tested organism as a control for growth of the bacterium. After 
incubation at 37 ºC for 24 hrs, 10 µl of 0.1% resazurin was added to all wells and incubated in 
the dark for 3 hrs. Absorbance was measured after incubation at 630 nm with an ELISA reader 
(BioTek ELx808, USA). The test was performed in triplicates for each isolate against each of 
the tested bacteria. 
The MIC values were plotted using GraphPad prism (GraphPad Prism version 7.00 for 
Windows, GraphPad Software, La Jolla California USA, www.graphpad.com). The curve is 
defined into three main areas: a- area where the isolate has no effect on the tested bacteria in 
relation to the control growth, b- area of increased inhibition of growth and c- an area where 
there is no growth in comparison with the control (Figure 2.6). The MIC value marks the 





Figure 2. 6 Sigmoid-shaped curve 
Assessing the inhibition of organisms by measuring minimum inhibitory concentration using 
Gompertz model. 
 
 Cell culture 
The human cervical adenocarcinoma cell line (HeLa) was grown as monolayer in 
Dulbecco’s modified eagle medium (DMEM) supplemented with high glucose (4.5g/L) and 
L-glutamine (Sigma-Aldrich) containing 10% Foetal bovine serum (FBS) and 100 units/ml 
penicillin/Streptomycin, in a 5% humidified CO2 incubator at 37°C. Cells were subcultured at 
70%-80% confluency using 0.25% Trypsin-EDTA. 
 
 Cytotoxic activity 
2.9.1. MTT assay 
The antiproliferative effect of the extracts was measured with MTT (3-(4,5-Dimethyl-
2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide) reagent using three independent replicates. 
Hela cells were seeded in 96 well plate at a density of 4x105 cells/well in 100 µl culture 
medium. After incubation for 24 hrs, extracts were added at 5, 10, 15 and 20 µg/µl 
concentration to the cells and incubated for 24 hrs. Non-treated HeLa cells were used as 
control. The culture medium was removed after incubation and replaced with 100 µl of growth 
medium. A volume of 15 µl of MTT reagent (5 mg/ml) was added to the cells and incubated 
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for 3 hrs at 37°C. Thereafter, the supernatant was removed and replaced with 100 µl of DMSO 
to dissolve the coloured formazan crystals produced by MTT. Optical density was measured 
at 570 nm with an ELISA reader (BioTek ELx808, USA). The concentrations were 
transformed to log concentration values and the absorbance values were normalized to 
percentage of inhibition (PI) using the Graphpad Prism 7.04 statistical software (GraphPad 
Software Inc., USA) in order to calculate the IC50 values through non-linear regression using 
dose-response-inhibition analysis. 
 
2.9.2. DAPI (DNA-specific fluorochrome) staining 
Hela cells were treated with 5 and 20 µg/µl concentrations of the organic extract of each 
isolate in triplicates after 24 hrs of seeding. Non treated cells were used as a control. After 
incubation for 24 hrs, cells were fixed with 4% Paraformaldehyde (PFA) for 8 minutes. The 
fixed cells were washed in PBS and permeabilized with 0.1% Triton-X-100 for 10 minutes. 
After washing, the cells were stained with 1 µg/ml of DAPI (4′,6-diamidino-2-phenylindole) 
for 5 minutes at room temperature (RT) in the dark. After washing with PBS, stained cells 
were observed under the fluorescent microscope (IX53 Olympus, Tokyo, Japan). Apoptotic 
nuclear changes, based on chromatin condensation and nuclear fragmentation, in DAPI stained 
cells were used to quantify apoptotic cells. Images were captured at different fields and 
counting was done in three independent replicates of each sample. 
 
 Elicitation of isolates 
2.10.1. Effect of Bacillus subtilis 
To prepare B. subtilis cell lysate, a loopful of an overnight culture of B. subtilis was 
inoculated into a flask containing 25 ml of Luria Bertani broth and incubated at 37°C for 24 
hrs. The cells were centrifuged at 13,000 rpm for 5 min and then washed and resuspended in 
25 ml of sterile saline. To lyse the bacterial cells, the cell suspension was placed in boiling 
water for 30 min. As for the Streptomyces isolates, a vegetative inoculum was prepared as 
previously reported by Elibol et al., 1995. An inoculum of 1.2 x 108 spores/ml of each isolate 
were inoculated into 25 mL of ISP1 broth medium and cultured for 3 days in an orbital shaker 
at 180 rpm at 28 °C which was then used as a vegetative inoculum for the elicitation 
experiments. Each vegetative inoculum was added at 3% (v/v) of the 3 day culture and induced 
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with 0.3% (v/v) of lysed B. subtilis cells. Inhibitory activity of the filtrates was assessed using 
well diffusion method against E. coli, S. aureus and B. subtilis. Organic extraction was 
performed on isolate CSK1 cultivated with B. subtilis lysate only and antimicrobial activity 
was assessed using the well diffusion method. 
 
2.10.2. Effect of Ƴ-Butyrolactone (GBL) 
A vegetative inoculum of 1.2 x 108 spores/ml of each isolate was inoculated into 25 ml 
of ISP1 medium and cultivated with 0.2, 0.5, 0.7 and 1 % of Ƴ-Butyrolactone respectively and 
incubated at 28°C for 14 days. Ethyl acetate extracts was prepared as described previously in 
section 2.6. Antimicrobial activity of the organically extracted elicitation cultures were 
assessed with E. coli, S. aureus, C. albicans and S. cerevisiae on Mueller-Hinton agar medium 
using the disk diffusion method (Kirby Bauer method). MTT assay was performed as in section 
2.8.2, HeLa cells were treated with 5 and 20 µg/µl concentrations of organic extracts to assess 
cytotoxicity. 
 
2.10.3. Effect of N-acetylglucosamine (GlcNAc) 
Streptomyces isolates were inoculated into 25 ml of ISP1 medium supplemented with 50 
mM of GlcNAc and incubated at 28°C for 14 days. Antimicrobial and cytotoxic activity were 
assessed as in section 2.9.2. 
 
 Genomic sequencing and bioinformatics analysis 
Genomic DNA of all positive isolates was isolated with promega Wizard® Genomic DNA 
Purification Kit (Promega, USA) following the manufacturer’s recommendation for Gram 
positive organisms. The quality and quantity of the isolated DNA was verified by 1% Agarose 
gel electrophoresis and NanoDrop (Thermo Fisher Scientific). Genomes were sequenced using 
Illumina MiSeq platform (MicrobesNG centre, University of Birmingham).  
The reads were trimmed using Trimmomatic and the quality was assessed using in-house scripts 
along with Samtools, BedTools and bwa-mem software. Genome reads were de novo assembled 
using QUAST. Sequences were blasted to NCBI (National Centre for Biotechnology 
Information) for identification. Gene annotation was performed by Prokka for prokaryotic 
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genome annotation. Genetic classification based on biological systems and KEGG Pathways 
were analysed by RAST system. Biosynthetic Gene Clusters (BGCs) were identified by 
antiSMASH (version 4.1.0) and Prism 3 online platforms. 
 
 Liquid Extraction Surface Analysis (LESA) 
Three types of Streptomyces colonies were analysed with LESA: colonies produced from 
inoculation of strains on ISP1 agar medium (un-induced), colonies produced from inoculation 
of strains on ISP1 agar medium induced with 0.7% GBL and colonies produced from the 
inoculation of strains into ISP1 agar medium supplemented with 50 mM GlcNAc. LESA-MS 
spectra were obtained using the TriVersa NanoMateTM robotic pipette nanoelectrospray system 
(Advion, Ithaca, USA) attached to an Orbitrap Elite mass spectrometer (ThermoFisher 
Scientific, Germany). For lipid/small molecule analysis, the robotic pipette tip of the TriVersa 
NanoMateTM aspirated 3 µl from a well of a 96-well plate containing 1:1 ethanol-water, 
dispensed 2 µl onto the colony and then reaspirated 2.5 µl before nanoelectrospray ionisation. 
For protein/peptide analysis 3 µl of acetonitrile-water-formic acid (50:45:5) extraction solvent 
were aspirated; 2 µl of the solvent were dispensed whilst the pipette tip was held in contact 
with the surface of the colony. Contact was kept for 10 s followed by reaspiration of the 
solution into the pipette tip and infused into the mass spectrometer at 1.7 kV with a gas pressure 
of 0.3 psi. Most of the MS spectra were obtained in the 50 – 1500 m/z range and visualized by 
Xcalibur software (ThermoFisher scientific, USA). 
 
 Statistical Analysis 
The statistics of the study was performed using the student’s t-test. MIC concentrations 
were assessed using PRISM 7.04 (Graphpad software). The mass spectra data generated by 






















3.  Isolation and Activity of Streptomyces 
 Introduction 
Streptomyces have been isolated from many terrestrial habitats around the world but their 
abundance and ability to produce bioactive metabolites depend on their habitat geographical 
and environmental conditions (Dolotkeldieva and Totubaeva, 2006). Each bacterial 
community differs in their microbial flora based on ecological differences (Stubbendieck et 
al., 2016). A specific ecosystem is defined by the species it occupies. The higher the 
biodiversity in an ecosystem (more niches occupied) demands higher usage of resources and 
vice versa (Hunting et al., 2015). Streptomyces were discovered from cultivated soil with 
antagonism potential against some bacteria and were capable of producing novel antibiotics 
(Oskay et al., 2004). Diversity of Streptomyces can be influenced by the different plant species 
as these bacteria may grow in the humus layer (Jeffrey, 2008). In addition, plants can produce 
toxic chemical compounds against the Streptomyces and in return resulting in the Streptomyces 
producing their own secondary metabolites. 
Bacterial neighbourhoods are governed by competition which is a vital part of 
communication between bacteria (Foster and Bell, 2012). Bacteria communicate and interact 
with other species while responding to external environmental conditions. Bacteria’s ability to 
distinguish interspecies signals and environmental changes is reflected in their bacterial 
genome. For example, Bacillus subtilis has many genes that are considered “non-essential”, 
yet these genes can play an important role in their defence against competitors (Sansinenea 
and Ortiz, 2011).  Streptomyces produce a variety of important enzymes as an outcome of their 
interactions with other microorganisms in biodiverse communities. These secondary or 
specialized metabolites are produced in response to environmental changes. Soil bacteria are 
governed by external stresses such as heat, drought and UV (Van der Meij et al., 2017). 
Extreme habitats are becoming major interest for scientist in the isolation of novel 
Streptomyces. Novel strains imply new gene clusters synthesizing new secondary metabolites. 
Extreme environments such as extreme temperature, pH and salinity may lead to the 
identification of new strains of Streptomyces. 
UAE is an underexplored habitat with a hot desert climate, the climate is harsh with 
temperatures ranging between 40 and 50 °C for most of the year with lowest of 20 °C reached 
for not more than 2 months of the year. Rainfall is uncommon in the UAE and does not last 
for long, it is in the form of downpours during the winter season. Another important factor to 
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consider is the sandstorms that are common during the summer season and it may last for 
several days which can allow horizontal gene transfer between bacterial communities. This 
climate is considered an extreme habitat that should be explored to identify novel Streptomyces 
containing new gene clusters. In this study, isolation and screening of Streptomyces species 
from UAE terrestrial habitat were performed. The ability of the isolated strains to produce 
inhibitory bioactive compounds was explored. We identified some species to possess 







































3.2.1. Isolation of Streptomyces from Terrestrial Habitats 
Streptomyces spores are more resistant to desiccation than other bacteria, therefore the 
collected soil samples were air dried for 24 hrs before processing to eliminate the growth of 
other bacteria in the sample. In addition, Streptomyces flora was enriched by heating the 
samples in a 55 °C water bath for 30 minutes with shaking to free the spores that can be trapped 
by the soil particles and the heat to eliminate the growth of pathogenic bacteria.   
The above pretreatment methods resulted in the isolation of 15 Streptomyces isolates 
(Table 3.1) after 7-10 days of plating 0.1 ml of the serially diluted samples on starch casein 
agar (SCA). Isolates were identified according to the genus description of Shirling and Gottlieb 
(Shirling and Gottlieb, 1966) indicated by chalky, discrete, powdery and velvety aerial 
mycelium which is a unique feature of the genus (Figure 3.1). The colony sizes ranged between 
small to medium with white, yellow, brown and grey in colour. Each isolate was streak purified 
on SCA medium and oatmeal agar medium for further morphological characterization and 
antimicrobial activity (Figure 3.2). 
 
Table 3. 1 Identified isolates and their locations 














CSO1 Oud Al Mateena
CSU1 University of Sharjah
CSU2 University of Sharjah







Figure 3. 1 Steptomyces isolated from terrestrial samples 
Soil sample isolated from Al Khawaneej area was serially diluted soil (10-1 to 10-5), each 
dilution was plated on starch casein agar (SCA) to isolate Streptomyces. Dilution 10-3 showed 
colonies showed distinct features of  Streptomyces colonies resembled by chalky and 
powdery colonies of various colours ranging from white, beige, yellow, brown and greyish-







Figure 3. 2 Streak purified Streptomyces isolated from soil. 
Isolates exhibiting small chalky and velvety colonies were streak purified on starch casein and 
oatmeal agar medium for further characterization. The above isolates (CSK1, CSK3, CSG1 & 
CSM1), observed on starch casein medium, show distinct features for Streptomyces as reported by 
Shirling and Gottlieb (Shirling and Gottlieb, 1966) with earthy smell due to the presence of the 
volatile metabolite, geosmin, produced by actinomyces. 
 
 
3.2.2. Screening for antimicrobial activity of isolated Streptomyces strains 
The antimicrobial activity was assessed for all of the isolates using the disk diffusion 
method (Bauer et al., 1966) against E. coli and S. aureus. Positive isolates showed Zones of 
inhibitions (clearance of growth) around the disks against both E. coli and S. aureus (Figure 
3.3) or against one of them. The isolates that showed inhibitory effect against both E. coli and 
S. aureus (CSK1, CSK3, CSW2, CSU1, CSU2 and CSG1) were tested against C. albicans and 








Figure 3. 3 Inhibitory activity of Streptomyces isolates against bacteria 
Disks of 10 mm in size of the Streptomyces isolates were cut from streak purified starch 
casein agar (SCA) medium and placed on mueller hinton agar plates that were spread with 
either E. coli or S. aureus to assess the inhibitory effect of the isolates by observing clearance 





Figure 3. 4 Inhibitory activity of Streptomyces isolates against fungus 
Ten millimetre disks were cut from streak purified Streptomyces isolates (CSK1, CSK3, 
CSW2, CSU1, CSU2 and CSG1) on SCA and placed on mueller hinton agar plates that were 
spread with either S. cerevisiae or C. albicans. Inhibitory activity of the tested isolates was 






Positive isolates that showed inhibitory activity against E. coli, S. aureus, C. albicans 
and S. cerevisiae by the disk diffusion method were inoculated into ISP1 medium for 10-14 
days and production of secondary metabolites was monitored. The culture filtrate (filtered 
supernatant) of each isolate was assessed by the well diffusion method (as described in section 
2.4.2) using E. coli, S. aureus, C. albicans and S. cerevisiae. Table 3.2 shows the average 
values of the zones of inhibitions (ZOI) of 3 independent experiments and the standard 
deviation was calculated for each sample. Six (CSK1, CSK3, CSW2, CSU1, CSU2 and CSG1) 
out of the 15 isolates showed inhibitory activity against E. coli and S. aureus with zones of 
inhibition ranging between 16 and 26 mm including the 5mm disks. The strains showed greater 
antifungal activity when tested against S. cerevisiae and C. albicans with zones of inhibition 
ranging from 17 to 35 mm (Figure 3.5). Isolate CSM1 showed no antimicrobial activity against 
any of the above organisms and was used as a negative control in the project. 
 
 
Table 3. 2 Zones of inhibition measured by well diffusion method 
Well diffusion method was used and zone of inhibition measured for the six positive strains in 
triplicates and standard deviation calculated 
 
 




mm ± SD 
C. albicans, 
mm ± SD 
CSK1 18 ± 2.08 20 ± 0.58 22 ± 1.73 35 ± 2.31 
CSK3 16 ± 0.76 14 ± 0.36 19 ± 0.58 34 ± 0.58 
CSW2 16 ± 0.58 18 ± 0.58 20 ± 2.08 35 ± 1.15 
CSU1 16 ± 2.89 25 ± 1.15 17 ± 1.53 30 ± 2.08 
CSU2 17 ± 0.58 26 ± 1.53 17 ± 0.58 27 ± 0.14 











Figure 3. 5 Inhibitory effect of Streptomyces isolates by well diffusion method.  
Filtrates of each Streptomyces strain was isolated from fermented culture broth. The filtrates 
were tested by well diffusion method against E. coli, S. aureus, S. cerevisiae and C. albicans 
using Mueller hinton agar medium. All the isolated strains’ filtrates (CSK1, CSK3, CSW2, 
CSU1, CSU2 and CSG1) showed inhibitory activity against the tested organisms except for 







3.2.3. Phenotypic characterization 
The selected six isolates were observed as Gram positive filamentous bacteria with 
branching hyphae from aerial mycelium under the light microscope. Morphological 
characterization on SCA (Figure 3.6) and oatmeal agar medium showed aerial mycelium 





Figure 3. 6 Morphological characterization of positive Streptomyces isolates 
Isolates obtained from soil samples were streak purified on starch-casein agar medium to 
further identify and characterize the isolates morphologically. 
 
A range of phenotypic properties were tested such as colour of aerial and substrate 
mycelium (Table 3.3). Melanoid pigments of light brown were produced by CSK1 and CSK3 
and black for CSM1 on ISP7 (Tyrosine agar) medium only. All isolates were negative for 
Hydrogen Sulphide production and positive for catalase. The ability of the isolates to utilise 
different carbon sources such as inositol, L-arabinose, xylose and sorbitol (carbon sources were 
chosen based in their availability in the lab) was assessed using glucose as positive control. 
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Inositol being utilised by all isolates except CSM1 (negative control) while the least utilized 
by all isolates was xylose and sorbitol.  
 
 
Table 3. 3 Phenotypic & biochemical characterization of Streptomyces strains 
Isolates were characterized according to the colour of their aerial and substrate mycelium. 
Data analysis was recorded based on + (positive) or – (negative) on observance. Production 
of brown colour pigment was observed for CSK3, CSU2 and CSG1. Isolates CSW2 and 
CSM1 were positive for utilization of inositol, L-arabinose, xylose and sorbitol while CSU1 
was negative for the utilization of these carbon sources. 
 
 
Isolates CSK1 CSK3 CSW2 CSU1 CSU2 CSG1 CSM1 
Colour of aerial 
mycelium White White White White White White Yellow 
Colour of substrate 
mycelium Yellow Grey Yellow Grey Grey Yellow Yellow 






brown - - - - Black 
Hydrogen sulphide - - - - - - - 
Catalase + + + + + + + 
Carbon source utilization 
Inositol + + + - + + + 
L-Arabinose + + + - - - + 
xylose - - + - - - + 




The characterization of spores has been an important identifying feature in the 
taxonomy of Streptomyces as they form when the organism undergoes stressful conditions 
leading to morphological differentiation which is linked to secondary metabolite production. 
Scanning electron microscopy examination showed spores with short chains of rod-shaped 
morphology (Figure 3.7). Spore surface was observed to be smooth for CSK1 and CSK3 and 




Figure 3. 7 Electron Microscopy of Streptomyces’ spore surfaces 
Spore surface morphology of Streptomyces isolates was examined by Scanning electron microscopy at x 7000. Spiral chains of spores with 
smooth surface were observed in isolates CSK1 & CSK3 while isolates CSW2, CSU1 and CSU2 had a spiny spore surfaces observed by 
projections of different length and thickness (as described by Tresner et al., 1961). 
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3.2.4. Minimum Inhibitory Concentration (MIC) 
The susceptibility of each isolate was determined by broth microdilution method 
against E. coli, S. aureus, C. albicans, S. cerevisiae, E. coli-ESBL and B. subtilis. The 
minimum inhibitory concentration (MIC) for all isolates (organic extracts purified by ethyl 
acetate) was determined by resazurin-based turbidometric (TB) assay (Elshikh et al., 2016). A 
96 well microtiter plate was set up with the tested bacteria being standardized to optical density 
of 0.05 at 600 nm and extracts ranging in concentration from 0.12 to 30 µg/µl in twofold step 
dilutions. MIC values were calculated for each isolate with 3 independent replicates using 
Gompertz model (Lambert & Pearson, 2000) by Graphpad prism 4 software (Table 3.4). The 
values were quantified by plotting the OD of the bacterial growth on a logarithmic scale 
resulting in a sigmoid-shaped curve using Graphpad prism (Appendix A).  
It is concluded from the MIC values that all isolates were highly inhibiting Gram-
positive S. aureus bacterium with MIC values ranging between 0.21 and 0.29 µg/ml. 
Meanwhile, lowest antagonism was observed for E. coli-ESBL by all isolates of MIC values 
ranging between 6.16 and 10.91 µg/ml except for CSK3 which showed lowest antagonism 
against S. cerevisiae at 12.17 µg/ml.  
 
 
Table 3. 4 Minimum inhibitory concentration assessment of the isolates 
As described in section 2.7 of chapter 2. Values were quantified by the graphpad Prism 4 
software based on the Gompertz model. 
 
 Concentration µg/ml ± SD 
Isolate E. coli      S. aureus  C. albicans  S. cerevisiae  B. subtilis  E. coli-ESBL  
CSK1 4.03 ± 0.01 0.21 ± 0.01 1.97 ± 0.01 7.32 ± 0.01 2.54 ± 0.01 9.07 ± 0.02 
CSK3 1.91 ± 0.04 0.23 ± 0.02 4.61 ± 0.01 12.17 ± 0.01 6.53 ± 0.01 6.16 ± 0.02 
CSW2 4.72 ± 0.04 0.29 ± 0.02 4.13 ± 0.01 9.33 ± 0.01 3.58 ± 0.003 8.60 ± 0.03 
CSU1 1.97 ± 0.02 0.24 ± 0.02 3.98 ± 0.01 3.36 ± 0.01 7.36 ± 0.01 10.64 ± 0.03 
CSU2 1.97 ± 0.02 0.21 ± 0.01 4.25 ± 0.01 7.10 ± 0.02 10.91 ± 0.02 5.69 ± 0.01 






3.2.5. Cytotoxic Activity 
3.2.5.1. MTT Assay 
The antiproliferative effects of the extracts were assessed on HeLa cervical cancer cells 
using the MTT and DAPI staining. In the MTT assay Doxorubicin was used as a positive 
control isolate while CSM1 was used as negative controls. The growth of cancer cells was 
inhibited in a concentration-dependent manner (concentrations ranging between 5-20 µg/µl) 
for most isolates except CSK1 and CSU2 (Figure 3.8). The IC50 values were determined for 
isolates that showed cytotoxicity effect against HeLa cells using graphpad prism using Dose-
response inhibition (Table 3.5). The IC50 values ranged from 3.46 µg/µl for CSK3 to 9.74 µg/µl 
for CSU1. 
 
3.2.5.2. DAPI Staining 
The morphological changes induced by apoptosis were assessed by inducing Hela cells 
with 5 and 20 µg/µl of the Streptomyces organic extracts for 24 hrs. After fixing and staining 
the cells with DAPI, apoptosis was examined using nuclear DAPI staining. Apoptotic features 
such as DNA fragmentation and chromatin condensation were clearly observed in CSK1, 
CSW2, CSU1 and CSU2 specifically at 20 µg/µl (Figure 3.9), unlike the control (untreated 
HeLa cells) and the negative extract CSM1 which showed normal nuclei. Apoptosis was not 
observed for CSK1 and CSU2 isolates. Hela cells were counted to assess percentage of nuclear 












Figure 3. 8 Cytotoxicity of Streptomyces extracts on HeLa cells. 
HeLa cells were treated with different concentrations (5-20 µg/µl) of Streptomyces organic extracts. Cytotoxicity on the cancer cells was assessed 
with MTT assay with absorbance measured at 570 nm. Doxorubicin was used as a positive control and isolate CSM1 as negative control. The 
presented results are means of standard deviation for three independent experiment. Data was normalized to the mean, T-test was used to analyze 
two sample comparison assuming equal variance (*P<0.05 and **P<0.005).
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Table 3. 5  Dose response (IC50) values 









Figure 3. 9 Apoptotic Induction of Streptomyces organic extracts on HeLa cells. 
HeLa cells were cultured in the absence of extract (control) and in the presence of 5 and 10 
µg/µl of the Streptomyces ethyl acetate organic extracts including the CSM1 negative control 
isolate. After 24 hrs, the cells were fixed and stained with DAPI. Nuclear fragmentation was 








Figure 3. 10 Quantification of DAPI staining 
Morphological changes of Hela cells induced with Streptomyces extracts (CSK3, CSW2, 
CSU1 and CSG1) were observed and quantified. Apoptotic nuclear changes are expressed 




3.2.6. Isolation of Streptomyces from Marine Habitats 
Culturing of marine sediment samples did not produce any Streptomyces colonies. Yet, 
these samples which were collected from a variety of marine sediment areas along the coastline 
of the Arabian Gulf may have a great potential for the isolation of novel strains of 
Streptomyces. A variety of pretreatment and culturing conditions are required before we can 














Streptomyces are widely found in both terrestrial and aquatic habitats, predominantly 
affected by, nutrients, temperature, pH and moisture (Gilbert et al., 1995). Streptomyces are 
known for the isolation of a variety of bioactive compounds such as anti-viral, anti-tumour, 
modulator of immune response, various enzymes inhibitors, insecticide, anti-parasitic and 
bioherbicides (Sanglier et al., 1993; Thompson et al., 2002). These important bioactive 
compounds are strain-specific and are produced by Streptomyces secondary metabolites 
(Thompson et al., 2002). These secondary metabolites are formed in stress surroundings such 
as nutrient depletion and waste accumulation, usually in the stationary phase of their life cycle, 
making them highly dependent on environmental conditions. 
A total of 15 Streptomyces isolates were obtained from 8 soil samples collected from 
different locations in the eastern region of UAE. The disk and well diffusion method (also 
known as Kirby-Bauer method) measuring the zone of inhibition in diameter (mm) was used 
to assess the antimicrobial activity of the Streptomyces isolates against E. coli (Gram negative 
bacterium) and Staphylococcus aureus (Gram positive bacterium).  More than 70% (11 out 15) 
of the isolates showed activity against one or both of the tested bacterium. Six isolates (40%) 
showed bioactivity against both organisms with zones of inhibition ranging between 16-26mm 
in diameter as shown in Table 3, with maximal inhibition observed for CSK1, CSU1, CSU2 
and CSG1 isolates. In addition, the six positive isolates showed zones of inhibition ranging 
from 17-35 mm when tested on Candida albicans and Saccharomyces cerevisiae. However, 
these isolates showed higher activity against C. albicans than S. cerevisiae. This Zone of 
inhibition which is detected by clearance of growth of the microbe surrounding the tested 
isolate is due to the secondary metabolites produced by the extracted Streptomyces isolates. 
CSM1 isolate obtained from Al Mizhar area in Dubai showed no activity against any microbial 
organism and alternatively was used as a negative control in this project.  
The use of phenotypic characteristics plays an important part in the identification of the 
Streptomyces genus, in particular the distinct colony morphology exhibiting chalky, powdery 
and velvety aerial mycelium which were evidently observed in the isolated strains (Figure 12). 
All the isolates were positive for catalase capable of breaking down toxins produced from 
oxygen metabolism and negative for Hydrogen sulphide production but they exhibited 




The antimicrobial properties of the isolates have also been demonstrated by the resazurin-
based turbidometric (TB) assay to determine the MIC values against a variety of pathogenic 
bacteria. The results showed that all isolates secrete wide spectrum of antimicrobial agents 
which could inhibit the growth of both bacteria and fungus. The isolates exhibited high activity 
against Gram-positive bacterium S. aureus, moderate activity against E. coli and C. albicans 
and low activity against S. cerevisiae and multidrug resistant isolate E. coli-ESBL. These 
results correlate with many studies (Cwala et al., 2011; Nurkanto et al., 2012) which show that 
actinomyces exhibit good activity against Gram-positive bacteria and low or no activity against 
Gram-negative bacteria and this could be due to the biochemical structure of the outer 
membrane of the Gram-negative bacteria being surrounded by an outer membrane containing 
LPS (lipopolysaccharide) which make the cell wall impermeable to lipophilic compounds. 
The highest rate of deaths in the world is attributed to cancer with an estimation of 9.6 
million in 2018 (World health organization; Bray et al., 2018). Many studies have shown the 
ability of Streptomyces to produce secondary metabolites as an anti-cancer agent (Berdy, 2005; 
Demain and Sanchez, 2009). Toxicity assay of extracts (secondary metabolites) was initially 
examined by the change of morphology on HeLa cells, most of the cells were observed as 
adherent with angular and spindle shape (epithelial) but most of the cells lost these characters 
after treatment with increasing concentration of the extracts. Cell shrinkage, rounding and 
detaching of the cells and apoptotic bodies were observed indicating the toxic effect of the 
extracts on HeLa cells. 
The earliest changes noticed in apoptosis are attributed to shrinkage of cells and pyknosis 
which are the result of chromatin condensation. The apoptotic cell contains dark purple 
chromatin fragments in the nucleus, this is followed by the formation of apoptotic bodies which 
is the separation of cell fragments (Elmore, 2007). In order to assess apoptosis, induced by the 
isolated Streptomyces strains, DNA fragmentation and cell viability measurements of the 
extracts on HeLa cells by MTT assay and DAPI staining were demonstrated. The MTT (3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) tetrazolium reduction assay is 
used to assess cell viability by measuring the mitochondrial activity of viable cells by reducing 
the yellow tetrazolium MTT reagent into purple formazan crystal with the addition of DMSO. 
The quantity of formazan produced is presumed to be proportional to the number of viable 
cells (Twentyman and Luscombe, 1987). Viability of the HeLa cells decreased with the 
increase in the concentration of the extracts from 5 to 20 µg/µl specifically for cells treated 
with CSK3, CSW2, CSU1 and CSG1 extracts. Finally, morphological changes such as DNA 
fragmentation, nuclear condensation and inhibition of growth was evident after staining and 
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quantifying the treated HeLa cells with DAPI specifically for CSK3, CSW2, CSU1 and CSG1 
compared to the cells treated with CSM1 (negative control) and non-treated cells. 
As for the marine sediment samples, we believe that there is a great potential to find novel 
strains of marine Streptomyces as it is a promising underexplored source for secondary 
metabolites production. A possible explanation could be that most of the samples were 
collected under the water and the right depth for sample collection was not reached; 
nevertheless we could not isolate Streptomyces even from the samples that were collected after 
the tide had gone out. These samples will be processed again with a variety of nutritional and 


























































4. Elicitation of Isolated Streptomyces 
 Introduction 
In nature, all microbes co-exist with each other competing for nutrition and survival and 
therefore they develop defence systems that mainly rely on the production of secondary 
metabolites (Bertrand et al., 2014). In vitro, co-culturing microbes with each other may force 
this defence mechanism to increase the production of secondary metabolites that are already 
present or lead to the expression of silent biosynthetic gene clusters and therefore the 
production of new secondary metabolites (Vargas-Bautista, 2014). Elicitation of secondary 
metabolites is an arising approach to help in the production of new secondary metabolites. It 
is based on triggering the bacterial cells with external stimuli known as “elicitors” to induce 
stress resulting in the activation of genes involved in defence or inactivation of genes that are 
not involved in defence production of new secondary metabolites (Abdelmohsen et al., 2015).  
The exact mechanism for the elicitation of secondary metabolites by other microbes is not 
fully understood but it could occur in a number of ways (Marmann et al., 2014): physical 
interaction of the producer organism with other bacterial cells may stimulate production 
(Figure 4.1-A); production of siderophores or small signalling molecules such as ϒ-
Butyrolactone hormones by other bacteria which may produce them for quorum sensing 
(Figure 4.1-B); production of enzymes by the inducer that leads to activation in the producer 
(Figure 4.1-C); and finally by gene transfer which could result in the activation or repression 
of the secondary metabolite as a permanent change in the producer genome (Figure 4.1-D). 
Elicitation mechanism was implemented in this study by culturing the Streptomyces 
isolates with B. subtilis lysate, γ-Butyrolactone and N-acetylglucosamine. Antimicrobial and 
cytotoxic activities were assessed. Culturing CSK1 isolate with B. subtilis lysate and N-
acetylglucosamine resulted in change of the culturing medium to red which could indicate the 
production of undecylprodigiosin (RED). We, also, observed that culturing with GBL 
negatively affected antimicrobial activity against E. coli, C. albicans and S. cerevisiae for most 










Figure 4.1 Mechanisms for Biological elicitation of novel secondary metabolites 
Production of new secondary metabolites or the expression of silent genes may be caused 
by cell to cell interaction (A), production of small molecules (B), production of enzymes 







Elicitation based on cultivation with hormones (Gamma Butyrolactone, GBL), signalling 
molecules (N-acetylglucosamine, GlcNAc) and another microorganism (B. subtilis lysate) to 
induce silent biosynthetic genes or enhance the production of existing ones was studied based 
on the well diffusion method. 
 
4.2.1. Effect of Bacillus subtilis lysate on Streptomyces isolates 
The interaction between the two spore-forming bacteria Streptomyces sp. and Bacillus 
subtilis was studied by cultivating the two organisms as an attempt to induce a diverse 
production of secondary metabolites. Each Streptomyces isolate was induced with B. subtilis 
cell lysate and antimicrobial activity against E. coli and S. aureus using the well diffusion 
method was assessed after 6 days of culture. CSK1 isolate, only, induced with B. subtilis was 
able to cause inhibitory effect against S. aureus (Table 4.1; Figure 4.2A) compared to the 
control which showed no activity as expected (the isolated Streptomyces strains monocultures 
show activity between 14-21 days of culturing). Furthermore, the elicited culture physically 
changed to red in colour after 14 days of culturing with no such change observed in the 













Table 4. 1 Effect of B. subtilis lysate on Streptomyces isolates 
Zone of inhibition diameter measured in mm for Streptomyces isolates after 6 days of 
cultivation with B. subtilis lysate. Standard deviation (SD) was calculated for three 
independent replicates 
 
Sample E. coli mm ± SD 
S. aureus 
mm ± SD Observation 
CSK1-C - - - 
CSK1-B. subtilis lysate - 13.0±0.41 Red colour 
CSK3-C - - - 
CSK3-B. subtilis lysate - - - 
CSW2-C - - - 
CSW2-B. subtilis lysate - - - 
CSU1-C - - - 
CSU1-B. subtilis lysate - - - 
CSU2-C - - - 
CSU2-B. subtilis lysate - - - 
CSG1-C - - - 
CSG1-B. subtilis lysate - - - 
CSM1-C - - - 











Figure 4.2 Streptomyces isolates cultivated with B. subtilis. 
Isolates were separately cultivated with 3% (v/v) B. subtilis lysate (as reported by Elibol et al., 
1995) in ISP1 medium and inhibitory activity of the cultivation was assessed against S. aureus 
by the well diffusion method, Inhibition of growth was observed for CSK1 only. Isolate CSK1 
was monocultured in ISP1 medium and cultivated with B. subtilis lysate (B). After 14 days of 
incubation at 28 °C, red pigmentation was observed in the elicitation culture (n=3). 
 
 
4.2.2. Effect of ϒ-Butyrolactone (GBL) on Streptomyces isolates 
GBL is a microbial hormone that has been identified to cause secondary metabolism in 
Streptomyces. The hormone was co-cultivated with the Streptomyces isolates (CSK1, CSK3, 
CSW2, CSU, CSU2 and CSG1) at different concentrations of 0.2, 0.5, 0.7 and 1 %. After 14 
days of elicitation, extracts were tested against E. coli, S. aureus, C. albicans and S. cerevisiae. 
Well diffusion method was used to assess activity and zones of inhibition were measured in 









Table 4. 2 Antimicrobial zones of inhibition of Streptomyces isolates cultivated with GBL. 
 The diameter of the zones of inhibition was measured in mm for the Streptomyces isolates  
induced with various concentrations of GBL (0.2, 0.5, 0.7 and 10 %). The standard deviation 












Each isolate exhibited different inhibitory activities after induction against the tested 
organisms. All GBL induced Streptomyces isolates except for CSK1 have resulted in higher 
inhibitory activity against S. aureus compared to the monoculture (Figure 4.3 & 4.4). Same 
trend of higher inhibitory activity of the elicited culture was observed for CSK3 and CSW2 
against E. coli, with the highest zone of inhibition observed with 0.7% induction of GBL with 
CSK3 at 23.5 mm and 18.0 mm for CSW2 induced with 1% GBL compared to the non-induced 
with a zone of inhibition of 14.0 mm (Figure 4.3). In addition, inhibitory activity of the isolates’ 
elicited cultures ceased against C. albicans with the exception of isolate CSU2 which showed 
higher inhibitory effect when induced with 1% GBL (Figure 4.4B). The same effect of loss of 
inhibitory activity was also observed against S. cerevisiae except for isolate CSG1 which 
showed higher inhibitory activity when induced with 0.5% and 0.7% GBL (4.4C). Finally, 
CSK1-GBL cultivation failed to produce any inhibitory activity against all the tested 
organisms. The data is, also, represented as an increase or decrease in activity based on the 
measured zones of inhibitions compared to the control (non-induced isolate), where the control 
is taken as a baseline with a value of 0 against each of the tested organism (Figure 4.5). As 
shown in the figure, an increase in inhibitory effect was clearly observed of all the isolates’ 
elicitations (based on all or one of the induced GBL concentrations) against S. aureus, CSK3 





















Figure 4.3 Induction of isolates CSK3 and CSW2 with γ-Butyrolactone (GBL) 
Well diffusion method was used to assess inhibitory activity of isolates CSK3 and CSW2 induced with GBL at different concentrations (0.2, 
0.5, 0.7 & 1%) against E. coli and S. aureus. Zones of inhibition, observed as clearance of growth, were measured. For CSK3, zones of inhibitions 
were observed in the uninduced and induced isolate except for CSK3 induced with 0.2% GBL (A). As for CSW2, zones of inhibition were 










Figure 4.4 Induction of isolates CSU1, CSU2 and CSG1 with γ-Butyrolactone (GBL). 
Isolates CSU1, CSU2 and CSG1 were induced with GBL at different concentrations (0.2, 0.5, 0.7 & 1%) and well diffusion method was used 
to assess inhibitory activity against E. coli and S. aureus. Zones of inhibition were observed for uninduced and induced CSU1 isolate against 
S. aureus except for CSU1-0.2% (A). The same trend was observed for CSU2 against S. aureus and C. albicans (B). Uninduced and induced 
















Figure 4.5 Differences in inhibitory activity of isolates induced with GBL 
Main effect of GBL induction on the inhibitory activity of the isolates against E. coli, S. aureus, C. 
albicans and S. cerevisiae was generated based on the produced zones of inhibitions, and the zone 
of inhibition measurement for the non-induced isolate was taken as the baseline. An increase of 
inhibitory activity was observed for all isolates against S. aureus, for CSK3 and CSW2 against E. 
coli, for CSU2 against C. albicans and finally CSG1 against S. cerevisiae. The presented results 
are standard deviation for three independent experiment. T-test was used to analyze two sample 




4.2.3. Cytotoxic Activity of Streptomyces isolates cultured with GBL 
HeLa cells were treated with non-induced CSK1, CSK3, CSW2, CSU1, CSU2 and 
CSG1, and isolates induced with 0.2, 0.5, 0.7 and 1 % GBL at two concentrations of 5 and 10 
µg/µl of the extracts to assess cell viability using the MTT assay (Figure 4.6). After 24 hrs of 
treatment, isolate CSK1 induced with 0.2% GBL showed significant decrease in cell viability 
for both 5 and 10 µg/µl concentrations although the control had no effect on viability. Induced 
CSK3 showed not cytotoxic activity on both concentrations of the extracts compared to the 
non-induced which showed significant cytotoxic effect for the concentrations. Isolate CSW2 
induced with 0.2, 0.5, 0.7 and 1 % GBL showed significant decrease in cell viability at 
concentration of 10 µg/µl only compared to the non-induced where a decrease in cell viability 
was observed for both 5 and 10 µg/µl concentrations. A decrease in viability was observed for 
HeLa cells treated with non-induced CSU1 at 5 and 10 µg/µl extract concentration and when 
the cells were treated with 10 µg/µl extracts induced with 0.2 and 0.7 % GBL. Viability of 
HeLa cells was also decreased when they were treated with CSG1 induced with 0.5 % of GBL 
at extract concentration of 10 µg/µl. Induced CSK3 and CSU2 showed no effect on the viability 
of the HeLa cells. The same trend of results was observed for the non-induced isolates when 



















Figure 4.6 Cytotoxic activity of Streptomyces isolates induced with GBL against HeLa cells. 
Cell viability of HeLa cells was measured using MTT assay. The graph represents cytotoxic effect of the isolates (CSK1, CSK3, CSW2, CSU1, CSU2 and CSG1) 
induced with different concentrations (0.2, 0.5, 0.7 and 1%) of Gamma Butyrolactone compared to the non-induced isolate. The Hela cells were treated with 5 and 
10 µg/µl of the non-induced and induced isolates for 24 hrs. Data is expressed as means of standard deviation (n=2) and analysed using T-test two sample comparison 
assuming equal variance (*P<0.05 and **P<0.005). 
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4.2.4. Effect of N-acetylglucosamine (GlcNAc) on Streptomyces isolates 
Streptomyces isolates (CSK1, CSK3, CSW2, CSU1, CSU2 and CSG1) were cultured 
with 50 mM of N-acetylglucosamine (GlcNAc) as a signalling molecule to assess changes in 
the inhibitory effect and cultural changes. After 7 days of culturing, GlcNAc had a stimulating 
effect on CSK1 antibiotic production where a zone of inhibition of 16.5 mm and 17 mm was 
observed against S. aureus and B. subtilis respectively (Figure 4.7-A) compared to no activity 
of the non-induced isolate as expected (Streptomyces isolates usually show activity after 14-
21 days of culturing). Furthermore, red-pigmented culture was observed after 14 days of 
culturing (Figure 4.7-B) compared to no colour change in the monoculture. 
It is worth mentioning that the physical characteristics of the colonies on the agar plate 
change to smaller in size and lose their chalky and powdery appearance when isolates are 
induced with GlcNAc, this effect is shown in Figure 4.7-C for CSK1 isolate. The same effect 
is also observed of the mycelium in broth culture changing from big in size of the non-induced 
to smaller mycelium size of the induced isolates. This change was consistent for all of the 
isolates.  
The red colour produced from CSK1 cultivated with B. subtilis and induction with 
GlcNAc may imply the production of Prodigiosins (PGs), a family of red pigmented secondary 
metabolites that are produced by Streptomyces and other bacteria and found to have anticancer, 
antimalarial and antimicrobial activity (Fürstner, 2003). Therefore, cytotoxicity of the ethyl 
acetate extracts of CSK1 cultivated with B. subtilis and induced with GlcNAc was assessed by 
MTT assay. Figure 4.8 clearly shows the antiproliferative activity of the induced CSK1 isolate 
compared to uninduced with a statistically significant decrease with the extracts at 




















Figure 4.7 CSK1 isolate induced with GlcNAc 
Inhibitory activity of CSK1 induced with 50 mM of GlcNAc resulted in a clear zone of 
inhibition of against S. aureus and B. subtilis after 7 days of culturing compared to uninduced 
which showed activity after 14 days of culturing (A). The CSK1-GlcNAc culture changed to 
red colour after 14 days of culturing compared to no change in colour of the uninduced isolate 
(B). In addition, colony morphology has changed from white and chalky appearance of the 








Figure 4.8 Effect of induced CSK1 isolate on HeLa cells 
HeLa cells were treated with uninduced CSK1, CSK1 cultivated with B. subtilis lysate and 
CSK1 induced with 50 mM GlcNAc at 5 and 20 µg/µl concentrations of the ethyl acetate 
extracts. Antiproliferative effect of the treatments was assessed by MTT assay. A decrease 
in the viability of HeLa cells was observed in the elicited culture and induced extracts 
compared to the treatment of the uninduced extract and non-treated HeLa cells. The 
presented results are means of standard deviation for two independent experiment. Data was 
normalized to the mean, T-test was used to analyze two sample comparison assuming equal 




The isolated Streptomyces strains are terrestrial Gram positive microorganisms. They exist 
in natural soil habitat that is rich with other microbes. This co-existence usually results in 
competition for survival triggered by the depletion in nutrients which leads to the production 
of secondary metabolites. Growing Streptomyces in vitro may result in inactivating or silencing 
the production of these secondary metabolites. Genome sequencing results have shown that 
Streptomyces contain many inactive biosynthetic gene clusters (Bentley et al., 2002; Nett et 
al., 2009) may be due to the in vitro cultural conditions which lacks the inter and intra-species 
communication mediated by the transfer of small signalling molecules between species. One 
way of eliciting or stimulating the expression of silent biosynthetic genes or increase the 
production of secondary metabolites is co-culturing. 
Many studies showed that co-culturing organisms together can lead to the effect of one 
organism affecting secondary metabolism in the second organism. B. subtilis is a Gram positive 
bacterium that is commonly found in soil and it has been identified in plant rhizosphere (Val 
et al., 2009). Since the Streptomyces strains in this study were isolated from cultivated soil in 
farms then most probably the two bacteria co-existed in nature. B. subtilis cell lysate was used 
in this study as a strategy to study elicitation where 3% of the culture was from Streptomyces 
isolates and 0.3% from B. subtilis. We have showed that cultivating the two organisms resulted 
in a red pigmentation (colour change) in the fermentation medium of CSK1 isolate after 14 
days of culturing which was not observed in the cultivation of the monoculture. In addition, 
cytotoxicity in Hela cells was induced when they were treated with the elicited extract 
compared to the monoculture extract. This result may suggest the production of 
undecylprodigiosin (RED), an antimicrobial antibiotic produced by Streptomyces coelicolor 
(White and Bibb, 1997) that also has a cytotoxic effect on breast cancer cells (Ho et al., 2007). 
Studies have shown that co-culturing S. coelicolor with B. subtilis increased the production of 
RED (Luti and Mavituna, 2011) in S. coelicolor. In addition, inhibitory activity of the CSK1 
isolate against S. aureus and B. subtilis was observed after 6 days of the elicitation compared 
to inhibitory activity between 14-21 days for the monoculture. The cultivation of CSK1 with 
B. subtilis may indicate the activation of silent biosynthetic genes and production of new 
secondary metabolites as the antimicrobial activity was observed about 8-15 days earlier than 
usual. Furthermore, RED is probably one of the produced secondary metabolites in the co-




Another approach to activate the silent biosynthetic gene clusters is cultivating the isolates 
with ϒ-Butyrolactone (GBL). GBL is produced by most Streptomyces (Horinouchi and Beppu, 
1992) and appear to be mainly involved in production of secondary metabolites (Horinouchi 
and Beppu, 1994). GBL are signalling molecules that are also known as autoregulators, they 
bind to structural receptors that are mainly involved in the expression of biosynthetic clusters. 
The results show that there was significant increase of inhibitory activity for CSK3 and CSW2 
isolates when induced with different concentrations of GBL against E. coli and S. aureus 
compared to the control (the monoculture). The same increased effect was also observed for 
CG1 against S. aureus and S. cerevisiae. This increased activity could be due to the diffusion 
of the GBL through the cell membrane and regulating the expression of the biosynthetic genes 
and production of secondary metabolites by either activating or suppressing genes that encode 
for enzymes involved in secondary metabolism (Niu et al., 2016). 
Cytotoxicity effect of isolates induced with GBL on HeLa cells was examined. The results 
revealed that CSK1 isolate induced with 0.2% GBL had a toxic effect on the breast cancer cells 
compared to the non-toxic effect of CSK1 isolate alone. In addition, there was no increased 
cytotoxicity effect of GBL induced CSK3, CSW2, CSU1 and CSG1 isolates; on the contrary, 
there was a decrease in toxicity of the induced isolates on the HeLa cells. These results may 
imply that GBL has induced activation of silent biosynthetic clusters with antimicrobial and 
not anti-tumour properties or turned off repressor genes. 
Studies have shown that high concentrations of GlcNAc keeps S. coelicolor in the 
vegetative state and that progression to sporulation happens only when the environmental 
conditions changes such as a decrease in GlcNAc (Rigali et al., 2006). Rigali group has also 
shown that GlcNAc inhibits antibiotic production in highly nutritive media but it activates red-
pigmented antibiotic undecylprodigiosin (Red) production in poor nutritive media in S. 
coelicolor (Rigali et al., 2008; Chater, 2001) bld genes which are produced at the beginning of 
aerial development with a loss of the aerial mycelium resulting in a “bald” phenotype. In this 
study, the culturing of ISP1 medium with 50 mM GlcNAc resulted in antimicrobial inhibition 
of all the isolates except for CSK1 which could be due to keeping the organism in the 
vegetative state and inhibiting antibiotic production. In addition, induced isolates showed 
colonies with a change of phenotype from chalky and powdery appearance due to the formation 
of aerial hyphae to small size colonies with “bald” appearance due to the lack of aerial hyphal 
formation. To the contrary from the other isolates, CSK1 isolate has resulted in early activity 
(after 7 days only) against S. aureus and B. subtilis and a red colour change in the induced 
culture which could be an indication for the production of RED. CSK1-GlcNAc extract 
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resulted in reduction of proliferation in HeLa cells and this could be due to the production of 
RED in the elicited culture. In order to have a marked effect of GlcNAc on the isolated 
Streptomyces strains the culturing media needs to be further examined and to see the difference 




























Genomic Sequencing &  


















5. Genomic Sequencing & Liquid Extraction Surface Analysis (LESA) 
 Introduction 
Genome analysis of bacteria have revealed that BGCs are clustered together and that they 
possess cryptic or silent secondary metabolites that had not been reported before (Corre and 
Challis, 2009). These silent BGCs are of interest to us as they may have inhibitory effect and 
may be potential to the discovery of natural products. Also, these BGCs are of interest because 
they possess genes that code for the modular enzymes PKS and NRPS which are involved in 
the production of secondary metabolites (Walsh and Fischbach, 2010). In addition, techniques 
such as HPLC and TLC have been used to identify BGCs, in this project a novel technique 
known as Liquid Extraction Surface Analysis (LESA) based on liquid microinjection 
combined with Mass Spectrometry (MS) will be used to identify peptides.  
Genome sequencing of each isolate was performed by using Illumina MiSeq platform and 
BGCs were identified by antiSMASH and Prism software. Then, Liquid Extraction of Surface 
Analysis was used to assess the differences between the mono-cultured strains and isolates that 
were cultured with GBL and GLcNAc. The data from the two systems were correlated to 
identify the BGCs that were common in both systems.  
 
5.1.1. Genomic Sequencing 
All the genes responsible for enzymes encoding secondary metabolism pathway are 
clustered together in a narrow locus known as biosynthetic gene cluster (BGC) (Cimermancic 
et al., 2014). Sequencing and metagenomics will allow us to discover a consortium of novel 
BGCs (Medema et al., 2015) that are capable of producing a variety of natural products that 
could be missed in the classical methods of fermentation and crude extraction (Winter et al., 
2011).  
One of the main breakthroughs in the identification of natural products is linking 
classical isolation and analytical analysis with genome mining. Genomic sequencing results 
have shown that Streptomyces sp. have larger genomes than other bacteria and about 5-10% of 
it is used for the production of silent secondary metabolites (Baltz, 2008). One very promising 
approach that can be used to identify these silent BGCs is to use genomic sequencing data to 
identify BGCs and compare them to known clusters based on pathway types such as PKS I, 
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PKS II, NRPS or RiPP, chemical structure classes, domain structure and conserved motifs of 
the synthesized natural product (Ward and Allenby, 2018). 
Many bioinformatics tools are now available for genomic identification of secondary 
metabolite biosynthetic gene clusters. “Antibiotics and Secondary Metabolite Analysis Shell” 
antiSMASH and Prism are the most common and comprehensive bioinformatics programs that 
can identify and annotate biosynthetic gene clusters (Niu and Tan, 2013). About 1346 BGCs 
have been detected by antiSMASH; some of the products are conserved among Streptomyces 
such as ectoine, hopene, siderophores, spore pigment, geosmin, butyrolactones and melanin.  
Whole genome annotation and comparative genomic analyses was performed on the 
seven Streptomyces strains including the control strain (CSM1). Several biosynthetic gene 
clusters were identified and other putative secondary metabolites were not identified. 
Phylogenetic analysis revealed the identification of novel Streptomyces isolates producing 
natural products that can be beneficial to the pharmaceutical industry. 
 
5.1.2. Liquid Extraction Surface Analysis (LESA) 
Environmental changes in the cultivation of Streptomyces such as composition of the 
media, pH, temperature and oxygen supply can lead to the production of various profiles of 
secondary metabolites for the same organism (Bode et al., 2002). More complex changes 
involving signalling molecules, communication and predators can also lead to the production 
of other secondary metabolites (Plaga et al., 1998). Typically, isolation of antibiotics involves 
solvent extraction, chromatographic separation and then using mass spectrometry for structure 
elucidation which is time consuming and does not always work as sometimes the spectra is too 
complicated and a relevant signal may be missed. Liquid extraction surface analysis (LESA) 
using Triversa Nanomate technology is a novel technique which is based on liquid 
microinjection method combined with high resolution mass spectrometry. LESA has been used 
to detect lipids, proteins and small molecules from a variety of surfaces such as plants, blood 
spots, tissue sections and food surfaces (Kai et al., 2012).The extraction system in LESA 
involves applying a droplet of solvent onto the surface via a robotic pipette tip, the droplet is 
kept for few seconds to form a liquid microinjection to allow the dispersion of the analyte 
molecules to the solvent. The sample is then transferred to the Orbitrap-elite mass spectrometer 
through the ionization of the analytes by a nano electrospray as explained previously in section 
1.7 and shown in Figure 1.9. 
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Strains grown on ISP1 broth produced antimicrobial and anticancer inhibitory agents 
as shown in chapter 3 of this thesis. Therefore, liquid extraction surface analysis (LESA) was 
utilized to distinguish and identify metabolites’ profiles directly from the bacterial colonies of 
the seven Streptomyces strains on ISP1 medium (un-induced), ISP1 medium induced with 






























5.2.1.  Genomic Sequencing and Annotation 
The isolated Streptomyces strains (CK1, CSK3, CSW2, CSU1, CSU2, CSG1 and 
CSM1) were sequenced using Illumina HiSeq at the microbesNG sequencing center of the 
University of Birmingham. A summary of the main principle features of the sequencing data 
is summarized in table 5.1 supplemented by the Microbe NG centre. The genome size of the 
strains ranged between 7.2 Mb to 7.7 Mb and GC content of all the strains was more than 72%, 
these assembly metrics were calculated by QUAST (quality assessment tool for genome 
assemblies; Gurevich et al., 2013). Taxonomic distribution of the isolates was calculated by 
Kraken (taxonomic sequence classification system), by assigning taxonomic labels to DNA 
sequences with high sensitivity and speed. Kraken has a database that contains k-mer records 
and the lowest common ancestor (LCA) of all organisms containing k-mers in their genomes. 
Classification is based on searching the database for each k-mer in a sequence. The LCA taxa 
generated was used to assign a suitable label for the sequence. Sequences with no k-mers in 
the databases are labelled “unclassified” which reduces false positive identification. Kraken 
database is built with 31 k-mers. Kraken has high sensitivity to identify the genus but 
sensitivity drops tremendously when the species are not known this is because Kraken relies 
on matches of long k-mers. Therefore, with novel organisms Kraken can accurately classify 
them at the genus level but not the species. Hence, the sequencing data identified the strains to 
belong to the Streptomyces genus with percentage similarity ranging between 56 to 62 % and 
very low contamination of 0.3 and 0.36 % with other genus. All of the strains had 12-13 % 
similarity with S. coelicolor species except for CSM1 (the control strain in the study) had 13.82 
% similarity with S. davawensis. Number of coding sequences and RNAs for each isolate was 





Table 5. 1 Genome features of the Streptomyces isolates 
Assembly metrics data generated using QUAST for # of contigs, total length and GC content 
parameters of the Streptomyces isolates sequenced by Illumina. As for the taxonomic 
distribution which shows the top genera that the reads map to was calculated by Kraken 
software. Annotation of the result was provided by the Microbes NG center at the University 







The genomes of the isolated strains were annotated using PROKKA (Seemann, 2014) 
for prokaryotic genome annotation to predict the main features of the generated sequences 
which will be publicly available upon request. 16S rRNA was extracted from the annotated 
data and phylogenetic tree was constructed based on evolutionary relationship of the isolates 
with other species of Streptomyces deposited at the National Centre for Biotechnology 
Information (NCBI) using the Mega X software (Figure 5.1). The phylogenetic analysis 
showed that the isolates shared distinct, but related, phyletic lines with other Streptomyces 
species. CSK1, CSW2, CSU2 and CSG1 were closely clustered together and to Streptomyces 
sp. E2N17. Isolates CSK3 and CSU1 showed close relationship in the phylogenetic 
dendrogram to each other and to Streptomyces sp. ETH927. CSM1 which is the negative strain 
in this project was closely related to CSK3 and CSU1 and to S. albogriseolus. The complete 
genomic sequencing data of each isolate when blasted to NCBI has revealed a 99 to 97% 
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identity with Streptomyces sp. ETH927 and Streptomyces sp. 4F with a Query coverage of 87% 
to 83%. The percentage identity then decreases to below 80% for the rest of the blasted 
Streptomyces species (Appendix B).  
RAST system was used to identify the open reading frames where the genes are classed 
into subsystems (based on gene and RNA sequence databases) (Table 5.2). The number of 
genes for certain subsystems was identified for each isolate, the most observed pattern deduced 
from the table is that in general, with few exceptions, the highest number of genes for each 
subsystem belonged to CSM1 which is the negative strain in the project followed by CSU1 
isolate. The highest number of genes are found in the “Amino Acids and Derivatives” and 
“Carbohydrates” subsystems followed by “Cofactors, Vitamins, Prosthetic Groups, Pigments” 
and “Protein Metabolism” subsystems. The lowest number of genes are found in “Phages, 
Prophages, Transposable elements, Plasmids”, “Motility and Chemotaxis” and “Secondary 
metabolism” subsystems. RAST identified 8 genes for CSU1 belonging to “Secondary 
Metabolism” followed by 7 genes for CSM1, 5 genes for CSK3, 2 genes for CSK1 and 1 gene 
for CSU2. KEGG metabolic pathways of the isolates was analyzed by RAST in comparison 
with S. coelicolor (most studied species in the Streptomyces genus) and to most identical 
species Streptomyces sp. ETH9427, as identified by complete genome BLAST (Table 5.3). 
CSU1 had the highest percentage of annotated proteins involved in various metabolic pathways 
alongside S. coelicolor followed by CSG1, CSK1, CSK3 and CSW2 with the lowest 
percentage correlation found with CSU1.  
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Figure 5. 1 Phylogenetic tree constructed by neighbor-joining method  
The evolutionary tree of the seven isolates’ 16S rRNA gene sequences to other Streptomyces 
specie was constructed. The tree shows the distant relationship between the CSM1 (negative 
control isolate in the project) and the rest of the isolates. Isolate CSK3 showed to be closely related 
to Streptomyces sp. ETH927. All the other isolates (CSK1, CSW2, CSG1 and CSU2) shared close 
distances with each other and to Streptomyces sp. E2N17. The phylogenetic tree of the 16S rRNA 
for the Bootstrap values based on 500 replicates are shown next to the branches. Jukes-Cantor 
method was used to calculate the evolutionary distances which is based on the number of base 
substitutions per site represented by 5% nucleotide sequence difference (scale bar). Evolutionary 
analysis was performed using MEGA X. The tree is rooted to M. tuberculosis as an outgroup. 
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Table 5. 2: Classification of isolates by RAST system 
The genes for each isolate were grouped into subsystems where the highest number of genes for 
a specific subsystem is denoted by green and the lowest by red. Streptomyces sp. ETH9427 was 
included as it has the highest identity to all isolates when blasted to NCBI but it has the lowest 
number of genes for each subsystem. S. coelicolor is the most characterized Streptomyces isolate 
and has the highest number of genes as shown in the table. As for the Streptomyces isolates, the 
highest number of genes for each subsystem was observed for isolate CSM1 followed by CSU1 











Table 5. 3 KEGG pathway comparisons of the Streptomyces isolates 
KEGG metabolic analysis of the isolates in comparison with published Streptomyces species was executed by using RAST system. EC number is used to 
link genomes to metabolic pathways, each enzyme is identified by an EC number that is organism specific. The percentage of ECs for a specific pathway 


















5.2.2. Identification of Biosynthetic Gene Clusters (BGCs) 
The Number and type of identified clusters for each isolate was analysed by 
antiSMASH version 4.1.0. The BGCs ranged between 25 to 29 with 27 cluster types identified 
for CSK1, 27 clusters for CSK3, 29 clusters for CSW2, 26 clusters for CSU1, 29 clusters for 
CSU2, 27 clusters for CSG1 and finally for CSM1 25 clusters were generated. A phylogenetic 
tree of the isolates with each other confirmed that CSM1 is distantly related from the other 
isolates and that CSK3 and CSU1 are closely related to each other. Figure 5.2 shows 
phylogenetic tree of the seven different isolates mapped with metabolites identified by 
antiSMASH with known cluster types, the highest number of clusters was observed for CSW2 
and CSU2 with 29 clusters and the lowest for CSM1 with 25 clusters. As observed from the 
figure, the distribution of the BGCs is very distinct for each isolate even when the isolates are 
closely related. The modular enzymes identified by antiSMASH of the isolated strains were 
between 10 and 15, with 10 modular enzymes identified for CSU1, CSG1 and CSM1, 13 for 
CSU2, 14 for CSW2 and 15 for CSK1 and CSK3.  
For CSK1 isolate, 27 clusters were identified in total with fifteen clusters consisting of 
modular enzyme coding genes for polyketide synthase (PKS) or non-ribosomal peptide 
synthetase (NRPS) or a hybrid of both were identified by antiSMASH. Six of the clusters were 
NRPS/PKS hybrids identified as polyoxypeptin_A (is a gene was identified to induce apoptosis 
against human pancreatic carcinoma cells; Du et al., 2014), antimycin (an antibiotic produced 
by Streptomyces sp. and has been annotated by antiSMASH to have antifungal and cytotoxic 
molecular activity), lipomycin (an antibiotic that inhibits the growth of Gram positive 
bacteria), meridamycin (is a non-immunosuppressant polyketide that plays a great role in the 
treatment of neurological disorders; Sun et al., 2006), chlorizidine_A (an anti-tumour agent 
with cytotoxicity effect on human colon cancer cells; Alvarez-Mico et al., 2013) and splenocin 
(anti-inflammatory antibiotics that inhibit a wide range of cytokines and therefore considered 
useful in the treatment of asthma). Five clusters were classified as NRPS type, two were 
identified as JBIR_34 (has no known function) and naphthyridinomycin (antimicrobial and 
antitumor activity; Pu et al., 2013) while the other three were not correlated to any known 
clusters. As for the PKSs: T1PKS as meilingmycin (an antiparasitic macrolide produced by S. 
nanchangensis and is used as a pesticide in agriculture; Wang et al., 2010), T2PKS as spore 
pigment and two T3PKSs identified as herboxidiene (has antitumor activity; Lagisetti et al., 
2014) and alkylresorcinol (provides Penicillin Resistance in Streptomyces griseus; Funabashi 
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et al., 2008). A cluster classified as “other” was correlated to arginomycin (an antibiotic 
produced by S. arginensis that inhibits Gram positive bacteria and fungi; Argoudelis et al., 
1987). The other clusters belonged to non-modular enzymes. 
Six hybrid clusters were identified for CSK3 as Polyoxypeptin_A, antimycin, 
lipomycin, chlorizidine_A, sanglifehrin_A (an immunosuppressant; Zhang and Liu, 2001) and 
griseoviridin/viridogrisein (antibiotics used against infections produced by multi-drug resistant 
bacteria synthesized by Streptomyces griseoviridis; Xie et al., 2017). Three NRPS clusters 
similar to naphthyridinomycin, coelibactin (plays a role in antibiotic regulation in S. coelicolor; 
De Montellano, 2005) and “unknown” clusters. T1PKS were correlated to 3 clusters with 
similarity to Isofuranonaphthoquinone (exhibits antibacterial and antioxidant properties in 
Streptomyces sp.; Fotso et al., 2003), Borrelidin (has antibacterial, antiviral and antimalarial 
properties isolated from S. rochei; Darna et al., 2011) and Nystatin-like-pseudonocardia-
polyene (antifungal compound; Kim et al., 2018). T2PKS was identified as spore pigment and 
T3PKS as herboxidiene and alkylresorcinol as observed with CSK1. Also, cluster identified as 
“other” was generated as arginomycin. 
CSW2 generated thirteen modular enzymes. Four hybrid clusters belonging to 
polyoxypeptin_A, antimycin, splenocin and sanglifehrin_A. NRPS clusters were identified as 
naphthyridinomycin, polyoxypeptin and three uncorrelated clusters. The non-ribosomal 
peptides were identified as naphthrydinomycin, and four “unknown” clusters. As for the PKSs 
clusters, T1PKS was reported as chlacomycin, T2PKS as spore pigment and T3PKS as 
Herboxidiene and alkylresorcinol. 
Isolate CSU1 was identified by 10 modular enzymes. Four NRPS/PKS hybrids similar 
to antimycin, sanglifehrin_A, splenocin and polyoxypeptin_A clusters. Three NRPS clusters 
identified as naphthyridinomycin, berninamycin (an antibiotic that inhibits protein synthesis in 
Gram positive bacteria produced by S. bernesis; Reusser, 1969) and “unknown” clusters. Three 
PKS classified as T2PKS with resistomycin (a pentacyclic polyketide produced by 
Streptomyces resistomycificus, it has cytotoxic effect against cancer cell lines and an 
antioxidant activity; Vijayabharathi et al., 2011) and spore pigment and T3PKS with 
alkylresorcinol. 
Sanglifehrin_A and naphthyridinomycin are the two hybrid clusters identified for 
CSU2. Piercidin_A1 (inhibits mitochondrial NADH dehydrogenase with antibacterial and 
antifungal activity; Hall et al., 1966), aurantimycin (exhibits inhibitory effect against Gram 
positive bacteria and antitumour activity; Gräfe et al., 1995), neocarzilin (antitumor compound; 
Otsuka et al., 2004), Antimycin and two “unknown” clusters were identified as NRPS clusters. 
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T1PKS clusters were identified as polyoxypeptin and antimycin; T2PKS as Spore pigment and 
resistomycin and T3PKS as alkylresorcinol. Finally, a cluster type classified as “other” was 
identified as polyoxypeptin. 
Ten modular enzymes were identified for CSG1 with polyoxypeptin, antimycin and 
naphthyridinomycin as the hybrid clusters; antimycin, glycopeptidolipid and three “unknown” 
clusters as NRPS type; spore pigment as T2PKS cluster and alkylresorcinol as the T3PKS 
cluster. 
Finally, CSM1had only one hybrid cluster belonging to sanglifehrin_A; four NRPS 
clusters in which two are identified as coelichelin (siderophore isolated from S. coelicolor; 
Tierrafria et al., 2011) and two as “unknown clusters”; one T1PKS classified as “unknown” 
cluster, two T2PKS identified as spore pigment and rabelomycin (angucycline antibiotic 
isolated from S. olivaceus with antibacterial activity against Gram positive bacteria; Kharel et 
al., 2010), one T2PKS-Butyrolactone cluster identified as fluostatins M-Q (angucyclins with 
special 6-5-6-6 carbon ring structure with unknown function; Jin et al., 2018). and one T3PKS 
cluster identified as germicidin (has inhibitory effect on spore germination; Petersen et al., 
1993). 
The biosynthetic assembly and predicted core structure were analysed for each cluster 
and the similarity of the cluster to other known genes and its presence in other Streptomyces 
species was identified using both Prism3 and antiSMASH databases (Appendix C). Appendix 
C shows the clusters that were identified by both tools only (more clusters were identified by 







Figure 5. 2 Phylogenetic tree and secondary metabolite gene clusters 
Neighbor-joining method was used to construct an evolutionary tree of the seven isolates using 
MEGA X. The phylogenetic tree of the 16S rRNA for the Bootstrap values based on 500 replicates 
are shown next to the branches. Jukes-Cantor method was used to calculate the evolutionary 
distances which is based on the number of base substitutions per site represented by 5% nucleotide 
sequence difference (scale bar). The bar plot represents the secondary metabolite gene clusters for 
each isolate identified by antibiotics and secondary metabolite analysis shell (antiSMASH). 
Different colours corresponding to different BGC types as shown in the key next to the bar plot.  
 
5.2.3. Liquid Extraction Surface Analysis (LESA) 
LESA-MS technology was used as a novel technique of direct sampling from the 
isolates’ bacterial colonies to determine and identify the metabolite profiles of each isolate 
using acetonitrile-water-formic acid solvent system. The mass spectra generated by LESA was 
classified or identified according to regions (Figure 5.3). The spectra were divided into 4 main 
regions and comparisons between the uninduced and induced spectra were based on these 
regions. The regions are colour coded based on their locations on the spectra. First region 
represents the peaks generated with the highest signals and generally they are between m/z 0-
550. Second region is between m/z 550-950 and denoted by a brown box and magnified brown 
spectrum. The next region is represented by blue box between m/z 950-1250 and blue 
magnified spectra and finally the fourth region is identified by green box with magnified green 
spectrum between m/z 1250-1500. 
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The mass spectra of uninduced CSK1 were analysed and Figure 5.4 represents the full 
scan where four distinct regions were identified. The first region between m/z 0-600 with 
charge of one and had the highest signals between m/z 0-300. The second region denoted by a 
brown box which is magnified as the brown spectrum shows peaks with doublet and triplet 
charges between m/z 650-1010. More intense peaks were observed in the m/z 1050-1120 region 
(blue box) with doublet charges (magnified blue spectrum) and the fourth region was marked 
by the green box (m/z 1100-1500) as shown by the magnified green spectrum with charges 
ranging between 6 and 9. The profile of the CSK1 isolate induced with GBL (Figure 5.5) 
changed from the uninduced, showing intense peaks with higher signals in the first region m/z 
0-600. The region between m/z 630 and 950 (brown box) had the same doublet charges but 
with peaks of higher signals than the uninduced spectra as shown by the brown coloured 
spectrum. Similar profile was observed for region m/z 1050-1120 (blue box) with doublet 
charges but with a lower number of produced molecules (blue magnified spectra). Peaks with 
charges between 6-9 (green box region in uninduced CSK1) was not observed in the in CSK1 
induced with GBL. Another change of profile was observed for CSK1 isolate when induced 
with GlcNAc (Figure 5.6), lower signal of peaks was observed for the region between m/z 0-
600 than CSK1 induced with GBL, yet it is higher than the uninduced CSK1. The doublet 
region denoted by brown box and spectrum was between m/z 650 and 880 with similar signal 
intensity as the uninduced and finally no doublet region was observed between m/z 1050-1100 
and the signal decreased tremendously. In addition, no region with charges between 6 to 9 in 
mass peaks greater than m/z 1200 as observed in the uninduced. 
As for isolate CSK3, the spectral signal between m/z 0-450 was low and no distinct 
regions of peak charges higher than 1 was observed (Figure 5.7) while CSK3 induced with 
GBL (Figure 5.8) generated dense peaks with high signals between m/z 0-600 and a distinct 
region of double charged peaks between m/z 725-770. As for CSK1 induced with GlcNAc 
(Figure 5.9), the peaks between m/z 0-450 had higher signals than the uninduced but lower 
than CSK1 induced with GBL. A distinct region of peaks with doublet charge was also 
observed but with masses of m/z 300-400, lower than mass region generated by CSK1-GBL. 





Figure 5. 3 Identification of mass spectra generated by LESA 
The spectra generated by LESA was divided into 4 distinct regions to analyze and compare the results between the uninduced and induced isolates 
systematically. The four regions are colour coded based on the location they represent. Main region of the spectra which represents the peaks with the highest 
signal is commonly between m/z 0-550 and represent the black coloured spectra. Second region is denoted by brown box and brown magnified spectra 
between m/z 550-950, third region between m/z 950-1250 is highlighted with a blue box and blue magnified spectra and the fourth region with green box 
and green magnified spectra is between m/z 1250-1500. 
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Figure 5. 4 LESA mass spectrum of isolate CSK1 
CSK1 colonies on ISP1 agar medium were analysed with LESA-MS system to identify potential metabolites using acetonitrile-water-formic acid (50:45:5) solvent, 
the spectra showed up to 15 kDa of different molecules. Doublet and triplet regions denoted by brown and blue boxes were identified (magnified regions of B &C) 





Figure 5. 5 LESA mass spectrum of CSK1 induced with GBL 
Colonies produced from the cultivation of CSK1 isolate on ISP1 agar medium induced with 0.7% GBL were analyzed by LESA-MS using acetonitrile-water-formic 







Figure 5. 6 LESA mass spectrum of CSK1 induced with GlcNAc 
CSK1 isolate was cultivated in ISP1 agar medium induced with 50 mM GlcNAc. Colonies were analyzed by LESA-MS system using acetonitrile-water-formic acid 







Figure 5. 7 LESA spectrum of isolate CSK3 
CSK3 colonies on ISP1 agar medium were analysed with LESA-MS system to identify potential metabolites using acetonitrile-water-formic acid 
(50:45:5) solvent, the spectra showed up to 15 kDa of different molecules. Peaks with the highest signals were observed between m/z 0-450. 
Doublet peaks were observed at different regions of the spectrum. 
 
      


































































Figure 5. 8 LESA mass spectrum of CSK3 induced with GBL 
CSK3 was cultivated on ISP1 medium induced with 0.7% GBL. Colonies were analyzed by LESA using acetonitrile-water-formic acid solvent. A 
region between m/z 725-750 (brown box) had various doublet peaks as shown in the magnified spectrum denoted with brown ovals. 
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Figure 5. 9 LESA mass spectrum of CSK1 induced with GlcNAc 
CSK3-GlcNAc colonies produced from CSK3 cultivated on ISP1 medium supplemented with 50 mM GlcNAc. The brown box region represents 
peaks produced of m/z 300-400 with doublet charge highlighted on the magnified spectrum by brown ovals. 
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Uninduced CSW2 mass spectra generated 3 distinct regions (Figure 5.10). The first 
region with the highest observed signal between m/z 0-450 with single charge. The next region 
produced doublet peaks between m/z 1060-1200 and the last region produced peaks with 
charge of 9 found between m/z 1300-1305 and another location of peaks with a charge of 8 
found between m/z 1465-1470. As for the mass spectra generated from CSW2 colonies induced 
with GBL a black coloured spectrum with dense and high signal peaks Figure 5.11) were 
observed between m/z 0-650 with a doublet region between m/z 680-690 denoted by magnified 
brown spectra, another region of doublet peaks was observed between m/z 1070-1180 (blue 
spectra). As for CSW2 induction with GlcNAc resulted in a spectrum lower in intensity (black 
peaks) than CSW2-GBL but higher than the uninduced CSW2 with single charge peaks (Figure 
5.12). 
LESA analysis of CSU1 isolate generated a spectrum of doublet charged peaks between 
m/z 650-855 (brown spectrum) and another region between m/z 1300-1470 with charges 
between 8-9 shown in the green magnified spectrum (Figure 5.13).   Low signal peaks between 
m/z 0-550 were observed for CSU1-GBL spectrum (Figure 5.14) compared to uninduced 
isolate, all peaks were of single charge.  Another change in the spectrum profile was observed 
for CSU1-GlcNAc where the peaks between m/z 0-500 were denser and higher in signal 
(Figure 5.15) compared to both the uninduced and CSU1-GBL with a region of doublet charge 
between m/z 750-900. 
Although there were only few high signals in CSU2 and they were concentrated between m/z 
0-160 as shown by the black peaks of figure 5.16, yet a region between m/z 1090-1190 had 
peaks with a charge of 6 (brown magnified spectrum). CSU2-GBL spectrum resulted in denser 
spectrum with a wider range between m/z 0-700 (Figure 5.17). As for CSU2-GlcNAc it 
generated a spectrum of high signal peaks between m/z 0-500 and a region with doublet peaks 




Figure 5. 10 LESA mass spectrum of isolate CSW2 
CSW2 was cultivated on ISP1 agar medium and colonies were analyzed by LESA. Two distinct regions were produced, a region between m/z 1070-1200 (blue box) 
with doublet peaks (blue spectrum) and a spectrum region between m/z 1300-1470 region with charges between 8-9 specifically the peaks in the spectra region between 
m/z 1300-1305 and 1465-1470 (green boxes), magnified regions shown as green spectra. 
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Figure 5. 11 LESA analysis of CSW2 induced with GBL 
CSW2 induced with GBL colonies mass spectrum shows three distinct regions of doublet charges. The first region was a dense spectrum between m/z 0-650 with high 
signal peaks. The second region represented by brown box on the main spectra and magnified as a brown spectrum with peaks of doubled charges was between m/z 
680-690. The last region with, also, doublet charges are between m/z 1070-1175 and shown as the blue spectra.  
  
      































































Figure 5. 12 LESA mass spectrum of CSW2 induced with GlcNAc 
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Figure 5. 13 LESA mass spectrum of isolate CSU1 
The highest signals were observed in the region between m/z 0-450 of the spectrum produced from the LESA analysis of colonies generated from the cultivation 
of isolate CSU1 on ISP1 agar medium. Two distinct regions were observed (brown and green boxes), a doublet region between m/z 560 and 850 (brown spectra) 
and a region of peaks with charges between 8 and 9 (green spectra).  
 
      


































































Figure 5. 14 LESA mass spectrum of CSU1 induced with GBL 
CSU1 isolate cultivated on medium induced with 0.7% GBL resulted in colonies that were analyzed by LESA. Peaks with the highest signals were produced 
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Figure 5. 15 LESA mass spectrum of CSU1 induced with GlcNAc 
Colonies of CSU1 isolate induced with GlcNAc were analyzed by LESA, spectrum had doublet peaks in various locations along the spectrum even 
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Figure 5. 16 LESA mass spectrum of isolate CSU2 
Colonies produced from CSU2 isolate on ISP1 agar medium generated a distinct spectrum (blue boxes) between m/z 10930-1190 when analyzed by 
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Figure 5. 17 LESA mass spectrum of CSU2 induced with GBL 
A mass spectrum was generated by LESA-MS from colonies of CSU2 induced with GBL on ISP1 agar medium. Peaks of the spectrum were 
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Figure 5. 18 LESA spectrum of CSU2 induced with GlcNAc 
CSU2 isolate was cultivated in ISP1 agar medium induced with 50 mM GlcNAc. The generated spectrum by LESA revealed a doublet region 
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CSG1 mass spectrum generated from LESA analysis revealed four distinct regions. 
The first region was shown as black dense peaks between m/z 0-450 (Figure 5.19). Another 
region between m/z 720-740 of peaks with triplet charge was identified (brown spectrum) 
followed by a region of doublet peaks denoted by blue spectrum in the figure ranging between 
m/z 1080-1100. Finally, the fourth region had distinctive peaks with charge of 8 observed 
between m/z 1365-1375. Denser peaks were observed for CSG1-GBL spectrum between m/z 
0-650 (Figure 5.20). Doublet peaks were observed at two different regions in the CSG1-GBL 
spectrum, with the first between m/z 680-870 and the second between m/z 1150-1195. As for 
CSG1-GlcNAc spectrum, 4 distinctive regions were identified with the high signal peaks 
region between m/z 0-450 (Figure 5.21); peaks with charges between 2-5 were observed as 
brown spectrum in the figure between m/z 625-965 followed by a region with peaks of charges 
4 and 5 (magnified as blue spectrum) between m/z 1090-1150 and the final region shown as 
green spectrum in the figure was a region of peaks between m/z 1370-1380 with peaks of 
charge 4. 
The last analyzed isolate CSM1 generated low signal peaks between m/z 0-500 by 
surface sampling which is commonly used on bacterial colonies and where there is no direct 
contact of the pipette tip containing the solvent (Figure 5.22A). Another sampling procedure 
was examined where the pipette tip was in direct contact with the colony which generated a 
high mass spectrum region between m/z 600-850 with doublet charges and another region 
between m/z 1100-1650 with peaks ranging in charge between 2 and 10 (Figure 5.22B). CSM1-
GBL spectrum had low signal peaks in the region between m/z 0-450 and a doublet region 
between m/z 680-860 magnified as a brown spectrum (Figure 5.23).  CSM1 colonies induced 
with GlcNAc generated spectrum with three regions (Figure 5.24); the first region was high 
signal peaks between m/z 0-450 followed by a region of doublet peaks (brown spectrum) and 





Figure 5. 19 LESA spectrum of CSG1 isolate  
Colonies of CSG1 grown on ISP1 agar medium generated a spectrum with four distinct regions when analyzed by LESA. High signal peaks were observed between 
m/z 0-450 with charge of 1. A region between m/z 670 and 810 (brown box) with doublet and triplet charged peaks (brown spectra). Another region of doublet 
charges (blue box) between m/z 1030-1150 (blue spectra) and a region with peaks of charge 8 (green box) between m/z 1365-1371 (green spectra). 
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Figure 5. 20 LESA mass spectrum of CSG1 induced with GBL 
Mass spectrum of CSG1 colonies induced with 0.7% GBL produced three distinct regions; a very dense region of m/z 0-600 peaks with charge of 1, another 
region between m/z 680-870 with doubled and triplet charged peaks and the final distinct region between m/z 1150-1195 with doublet charge peaks. 
 
  
      


































































Figure 5. 21 LESA mass spectrum of CSG1 induced with GlcNAc 
The spectrum generated by LESA of CSG1 induced with 50 mM GlcNAc had 4 distinct regions. A region with high signal and dense peaks between m/z 0-450 
(black peaks of the main spectrum), a region between m/z 620-970 (brown box) with peaks of charges between 2-5 (brown spectra), another region between m/z 
1050-1155 (blue box) containing peak spectra of charges 4-5 and a final region of m/z 1370-1380 with peaks of a charge of 4. 
 
 
      































































Figure 5. 22 LESA mass spectrum of CSM1 isolate 
Two spectra were generated for CSM1 colonies, the first spectra (A) was generated by surface sampling where there was no direct contact of the pipette tip 
in the LESA system with the colony which resulted in low signal peaks between m/z 0-600 and all the peaks in the spectra contained a charge of 1. The 
second spectra (B) was generated by direct contact of the pipette tip with the colony which gave a better signal of the overall spectra and produced a region 
between m/z 1100-1650 (red box) with peak charges ranging between 2-10 (magnified spectra outlined with red box). 
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High mass colony contact CSM1-uninduced (A) 
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Figure 5. 23 LESA spectrum of CSM1 induced with GBL 
The colonies of CSM1 induced with GBL resulted in low signal peaks between m/z 0-500 but there was a region between m/z 680-860 (brown 
box) with peaks of doublet charges as shown in the magnified brown spectrum. 
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Figure 5. 24 LESA mass spectrum of CSM1 induced with GlcNAc 
CSM1 colonies induced with GlcNAc generated dense peaks with high signal between m/z 0-450. In addition, two distinct regions were observed, one between 
m/z 500-865 with peaks of doublet charges and another region between m/z 1150-1410 with peaks of charge 6. 
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5.2.4. AntiSMASH and LESA BGC mass comparison 
The LESA mass spectrum for each isolate was analysed for the presence of biosynthetic 
gene clusters (BGC) that were identified by antiSMASH. Tables 5.4-5.10 summarizes the 
masses, ID and structure of the BGCs identified for each isolate with Δppm of less than 5.000 
(The generated mass peak for each compound are found in Appendix D). Cetoniacytone_A 
was identified in all isolates except for CSM1 (Appendix D: CSK1_213.063, CSK3_213.064, 
CSW2_213.064, CSU1_213.064, CSU2_213.064, CSG1_213.064 m/z). Desferrioxamine_B 
was identified in all isolates except for CSW2 (Appendix D: CSK1_560.686, CSK3_560.682, 
CSU1_560.682, CSU2_560.686, CSG1_560.686, CSM1_560.687 m/z).  
BGCs with “unknown” cluster type, as classified by antiSMASH, were: meilingmycin 
identified in CSK1 and CSU1 (Appendix D: CSK1_626.775 and CSU1_626.777 m/z); 
meridamycin in CSK1, CSW2 and CSU2 (Appendix D: CSK1_822.092, CSW2_820.078 and 
CSU2_820.075 m/z); arginomycin in CSK1 and CSK3 (Appendix D: CSK1_436.463 and 
CSK3_436.466 m/z); herboxidiene in CSK3 and CSW2 (Appendix D: 438.607 and 438.604 
m/z); JBIR-34 CSG1 (Appendix D_CSG1_480.897 m/z) ; lipomycin in CSK3 and CSU1 
(Appendix D: 587.701 and 578.701 m/z); chlorozidine in CSW2, CSG1 and CSM1 (Appendix 
D: CSW2_444.087, CSG1_444.087 and CSM1_444.089 m/z); herbimycin found in CSU1 
(Appendix D_CSU1_574.661 m/z).  
Seven modular enzymes were identified; in isolate CSK3 polyoxypeptin_A (T1PKS-
Butyrolactone, Appendix D_CSK3_969.145 m/z) was determined, in CSW2 splenocin (NRPS, 
Appendix D_CSW2_470.472 m/z), in CSU1 naphthyridinomycin (KS-NRPS, Appendix 
D_CSU1_417.550 m/z) and antimycin (T1PKS-NRPS, Appendix D_CSU1_534.600 m/z), in 
CSU2 polyoxypeptin_A, resistomycin (T2PKS) and splenocin (Appendix D: CSU2_969.141, 
CSU2_376.357 and CSU2_470.471 m/z) were found and finally isolate CSM1 had 
rabelomycin (T2PKS-Butyrolactone, Appendix D_CSM1_338.310 m/z) and coelichin (NRPS, 
Appendix D_CSM1_565.583 m/z) modular enzymes.  
The rest of the BGCs were terpenes such as albaflavenone found in CSK3, CSG1 and 
CSM1 (Appendix D: CSK3_218.335, CSG1_218.335 and CSM1_218.336 m/z); hopene in 
CSK1, CSK3 and CSM1 (Appendix D: CSK1_410.717, CSK3_410.719 and CSM1_410.712 
m/z); and carotenoid in CSK3, CSW2 and CSG1 (Appendix D: CSK3_213.064, 
CSW2_213.064 and CSG1_213.064 m/z). Informatipetin (bacteriocin) was identified in CSW2 
only (Appendix D_CSW2_1065.573 m/z). Ectoine was determined in CSK1, CSK3, CSG1 
and CSM1 (Appendix D: CSK1_142.155, CSK3_142.155, CSG1_142.155 and 
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CSM1_142.155 m/z). Finally, BGC sanglifehrin (other) was determined in CSK1 (Appendix 
D_CSK1_1090.393 m/z). 
Table 5.11 summarizes the BGCs that were identified by antiSMASH and masses 
observed by LESA-MS. We can observe that the isolates indeed produce different metabolites. 
All isolates except for CSM1 (the negative control isolate) produced a BGC cluster similar to 
cetoniacytone_A which is an antitumour agent. The siderophore desferrioxamine_B is an iron 
chelator and is a highly conserved gene cluster in Streptomyces was found in all isolates except 
for CSW2 which instead showed similarity to informatipeptin cluster which was, also, unique 
to that isolate. Informatipeptin is identified as a class III lantipeptide formed through the post 
ribosomal peptide synthesis. Unique cluster similarities were observed to each isolate. 
Sanglifehrin A is an immunosuppressant that belongs to the immunophilin-binding ligands 
was found in CSK1 isolate only; CSU1 isolate identified BGCs similar to naphthyridinomycin 
(a broad spectrum antibiotic), antimycin (inhibits mitochondrial electron transport chain 
complex III and suppresses tumorigenesis in lung cancer cells) and herbimycin (an antibiotic 
that inhibits protein tyrosine kinase and inhibitor of angiogenesis); CSU2 to resistomycin (an 
antibiotic that has an antioxidant activity and can be cytotoxic against cancer cell lines); CSG1 
to JBIR-34 (a nonribosomal peptide with uncommon 4-methyloxazoline moiety); and CSM1 
to rabelomycin (belongs to angucyclines antibiotics with antibacterial activity against gram 
positive microorganisms). All other clusters were common to two or three isolates.  
Three NRPS clusters were not identified to any known compounds by antiSMASH in 
CSK1, CSK3 and CSU2. NORINE, a nonribosomal peptide database (Caboche et al., 2010) 
was used to identify peptides through their annotations or monomeric structures. In CSK1, 
region 191.1, a polymer was predicted based on core scaffold assuming PKS/NRPS 
collinearity with (thr-val) in antiSMASH. A structure search in NORINE database of thr-val 
generated a list of peptides that were identified according to their similarity to the searched 
polymer (Caradec et al., 2014). N-coronafacoyl-L-valine peptide with mass of 307.178 and 
“toxin” activity was also observed by a peak at 307.175 m/z in LESA-MS of CSK1-GBL 
colonies and not in CSK1 colonies (Figure 5.25A). CSK1 NRPS regions 350.1 and 471.1 did 
not match any peptides in Norine database. For region 350.1, the predicted amino acid is: asp, 
asn, glu, gln, aad and it is not similar to any known compounds. As for region 471.1, the 
adenylation domain was not annotated and therefore amino acids can’t be predicted. 
As for CSU2, region 615.1 with mass of 487.304 was identified, based on (ala) polymer 
prediction, as beauverolide H cyclic peptide with unknown activity in NORINE which was 
observed as a peak of 487.303 m/z in CSU2-GBL LESA-MS (Figure 5.25B). The other two 
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unknown NRPSs in CSU2 are regions 405.1 and 500.1. Region 405.1 was predicted with val 
monomer identified to amycolamycins A and B (newly discovered enediyne-derived 
compounds with cytotoxic activity to the M231 breast cancer cell line.; Ma et al., 2017) but 
the compound could not be confirmed by LESA. As for region 500.1 the adenylation domain 
was not annotated and therefore amino acids can’t be predicted. 
 As for CSK3, region 476.1 in CSK3 was identified with two peptides under the name 
of tokaramide A (mass of 476.274) as a protease inhibitor and pepstatin (mass of 685.462) with 
unknown activity based on (val) polymer prediction and were observed by LESA as peaks of 
476.272 and 685.461 m/z respectively (Figure 5.26A). Additionally, geodiamolide C (mass of 
549.262) with antitumour activity and halipeptin B (mass of 612.356) with anti-inflammatory 
activity were identified by NORINE for region 547.1 based on (ala) polymer prediction and 






Table 5. 4 CSK1 BGCs identified by antiSMASH and LESA 
The masses of BGCs identified by antiSMASH were correlated to spectrum masses 
generated by LESA. The below molecules were identified by both systems for CSK1 isolate 





Table 5. 5 CSK3 BGCs identified by antiSMASH and LESA 
The masses of BGCs identified by antiSMASH were correlated to spectrum masses 
generated by LESA. The below molecules were identified by both systems for CSK3 isolate 





Table 5. 6 CSW2 BGCs identified by both antiSMASH and LESA analysis 
The masses of BGCs identified by antiSMASH were correlated to spectrum masses 
generated by LESA. The below molecules were identified by both systems for CSW2 






Table 5. 7 CSU1 identified by both antiSMASH and LESA analysis 
 
The masses of BGCs identified by antiSMASH were correlated to spectrum masses 
generated by LESA. The below molecules were identified by both systems for CSU1 isolate 






Table 5. 8 CSU2 BGCs identified by both antiSMASH and LESA analysis 
The masses of BGCs identified by antiSMASH were correlated to spectrum masses 
generated by LESA. The below molecules were identified by both systems for CSU2 isolate 










Table 5. 9 CSG1 BGCs identified by both antiSMASH and LESA analysis 
The masses of BGCs identified by antiSMASH were correlated to spectrum masses 
generated by LESA. The below molecules were identified by both systems for CSG1 isolate 







Table 5. 10 CSM1 BGCs identified by both antiSMASH and LESA analysis 
The masses of BGCs identified by antiSMASH were correlated to spectrum masses 
generated by LESA. The below molecules were identified by both systems for CSM1 







Table 5. 11 Summary of BGCs identified for each isolate 
The BGCs identified by both antiSMASH and LESA-MS analysis are summarized in the 
below table 
 
BGC CSK1 CSK3 CSW2 CSU1 CSU2 CSG1 CSM1 
Ectoine X X       X X 
Cetoniacytone_A X X X X X X   
Hopene X X         X 
Arginomycin X X           
Desferrioxamine_B X X   X X X X 
Meilingmycin X     X   X   
Meridamycin X   X   X     
Sanglifehrin_A X             
Albaflavenone   X       X X 
Herboxidiene   X X         
Lipomycin   X   X   X   
Carotenoid   X       X   
Polyoxypeptin_A   X     X     
Chlorizidine     X     X X 
Splenocin     X   X     
Informatipeptin     X         
Naphthyridinomycin       X       
Antimycin       X       
Herbimycin       X       
Resistomycin         X    
JBIR-34            X   











Figure 5. 25 Biosynthetic gene clusters encoding “unknown” NRPS product for CSK1 and CSU2 
NRPS clusters encoded in the CSK1 region 191.1 (A) and CSU2 region 615.1 (B) genomes and their protein domains as identified by 
antiSMASH with unpredicted product. Predicted domains and nonribosomal peptides are coloured by general function. Domain key: 
A-adenylation, C- condensation and TE- thioesterase. NORINE database (Caboche et al., 2010) was used to estimate peptides based on 




Figure 5. 26 Biosynthetic gene clusters encoding “unknown” NRPS product for CSK3 
NRPS clusters encoded in the CSK3 region 476.1 (A) and 547.1 (B) genome and their protein domains as identified by antiSMASH with unpredicted product. 
Predicted domains and nonribosomal peptides are coloured by general function. Domain key: A-adenylation, C- condensation and TE- thioesterase. NORINE 
database (Caboche et al., 2010) was used to estimate peptides based on antiSMASH polymer prediction. Masses of the peptides were confirmed by LESA-MS 




In this study, we report the use of genomics combined with metabolomics to characterize 
and identify secondary metabolites from seven strains of Streptomyces. Strains CSK1, CSK3, 
CSW2, CSU1, CSU2, CSG1 and CSM1were isolated from different cultivated terrestrial areas 
in UAE and its genomes were sequenced. Main features of the genomes such as size, GC 
content and coding sequences (Table 5.1) were typical of other Streptomyces. The 16S rRNA 
analyses distinctly showed that the isolates correlated to the Streptomyces genus (Figure 5.2). 
CSK1, CSW2, CSU2 and CSG1 were found to be closely related to each other and to 
Streptomyces sp. E2N17. Streptomyces sp. E2N17 is an unpublished strain with antimicrobial 
activity isolated from Fetzara Lake in the north eastern region of Algeria. Isolates CSK3 and 
CSU1 were closely related to Streptomyces sp. ETH9427 (Thibessard et al., 2018), this strain 
was previously described as Streptomyces ambofaciens ETH9427 (Hütter, 1967). As for 
CSM1, the negative isolate in the study was found to be closely related to S. albogriseolus 
ABRIINW EA1145 strain (unpublished strain). Whole genome sequence blast search revealed 
that all sequences were closest to Streptomyces sp. ETH9427 with 98% to 99% identity and 
query cover ranging between 34 to 91 % for the different isolates (Appendix B) except for 
CSM1 which was found closest to S. niger strain 452 with 98% identity and 82% query 
coverage.  
The seven isolates along with S. coelicolor (most studied and representative model of the 
genus) and Streptomyces sp. ETH9427 (closely related to all the isolates by whole genome 
blast) were genetically classified into subsystems by RAST system (Table 5.2). The highest 
number of correlated genes to a subsystem were identified in S. coelicolor followed by CSM1 
and CSU1 isolates with small differences in number. Streptomyces sp. ETH9427 had the lowest 
number of genes for most subsystems. Seventeen genes correlating to secondary metabolism 
were identified for S. coelicolor followed by 8 for CSU1 and, interestingly, 7 for CSM1. In 
KEGG pathway analysis, same trend was observed where the highest percentage of enzymes 
for the various pathways were observed in S. coelicolor followed by CSU1 which was very 
closely correlated and then CSM1 isolate (Table 5.3). In general, all isolates have demonstrated 
their involvement in the biosynthesis of antibiotics, sugars, siderophores, polyketides and 
terpenoids. 
We have found and demonstrated that all isolates were very similar to BGCs with 
antimicrobial and antitumor properties such as polyoxipeptin_A, arginomycin, meilingmycin, 
 
143 
antimycin, lipomycin, chlorizidine, herboxidiene, meridamycin, rabelomycin, herbimycin and 
splenocin. 
Direct sampling of the colonies generated by the isolates uninduced or induced with GBL 
or GLcNAc using acetonitrile, water and formic acid solvent was performed with liquid 
extraction surface analysis (LESA) to generate mass spectra of the produced metabolites. We 
have shown that the spectral profiles between the uninduced and induced isolates were 
different. This change was either in the appearance of new peaks, disappearance of others or 
increase of intensity in some. In this study, we have shown that some BGCs generated by 
antiSMASH were produced in the LESA analysis such as arginomycin, meilingmycin, 
meridamycin, herboxidiene, JBIR-34, lipomycin, antimycin, polyoxypeptin_A, 
cetoniacytone_A, chlorizidine, splenocin, naphthyridinomycin, herbimycin, resistomycin, 
coelichin and rabelomycin in addition to the commonly found core BGCs such as carotenoid, 
informatipeptin, ectoine, hopene, albaflavenone and desferrioxamine_B.  
Some of the putative NRPS-encoding clusters in CSK1, CSK3 and CSU2 showed no 
similarity to any reference BGCs by antiSMASH. The number of amino acids and molecular 
weight for these peptides were predicted by NORINE database and were further confirmed by 
LESA (Table 5.12). N-coronafacoyl-L-valine is a toxin that was predicted by NORINE 
database for CSK1 and a peak was observed in CSK1-GBL LESA spectra. NORINE database 
has determined beauverolide H peptide with unknown activity for one of CSU2 NRPS cluster 
blast and a peak was observed in CSU2-GBL LESA spectra. These results confirm that using 
GBL as an elicitor produced molecules that were not generated in the non-elicited strain. 
Finally, four peptides were identified for CSK3 as tokaramide A (protease inhibitor), pepstatin 
(unknown activity), geodiamolide C (antitumour) and halipeptin B (anti-inflammatory) and 
confirmed by the LESA spectra. Finally, the most interesting results were the three BGCs 
encoding for NRPS (CSK1-350.1, CSK1 471.1 and CSU2 500.1) that were not predicted to 






Table 5. 12 Properties of novel BGCs and Peptides 
NRPS Biosynthetic gene clusters, that were not correlated to known compounds by antiSMASH, were identified by NORINE database based on 


















Strain Cluster region Predicted monomer Peptide Activity LESA-MS m/z 
CSK1 NRPS 191.1 Thr-Val N-coronafacoyl-L-valine toxin 307.175 
CSK1 NRPS 350.1 asp, asn, glu, gln, aad unknown - - 
CSK1 NRPS 471.1 - - - - 
CSU2 NRPS 615.1 ala Beauverolide H unknown 487.304 
CSU2 NRPS 405.1 val Amycolamycins A and B cytotoxicity - 
CSU2 NRPS 500.1 - -  - 
CSK3 NRPS 476.1 val 
Tokaramide A protease inhibitor 476.272 
Pepstatin unknown 685.462 
CSK3 NRPS 547.1 ala 
Geodiamolide C antitumour 549.260 











































6. General Discussion 
Streptomyces are Gram positive bacteria that have been known as a rich source of 
producing secondary metabolites which have been used in clinical, biotechnological and 
agricultural aspects (Harir et al., 2018). They are found in environments with a variety of 
nutrients and they are capable of utilizing different carbon, nitrogen and phosphate sources. 
Typically, in scarce conditions cell growth ceases and aerial mycelium is formed which then 
differentiates into spores. This morphological change along with metabolic changes leads to 
the initiation of secondary metabolism. Spores are formed to resist the unfavourable 
environmental conditions and spread the bacterium. Under these famine conditions, the 
bacteria produce degradative enzymes such as lipases and proteases and form dry resistant 
exospores (Rigali et al., 2008). 
Screening for antibiotics has been done in the last 50 years and the urge to find new 
antibiotics has increased especially with the emergence of multi-drug resistant bacteria (Li and 
Webster, 2018). New approaches are required that should aim on selecting microorganisms 
that possess novel and potent antibiotics. The biosynthetic genes that encode for the production 
of secondary metabolites are located in clusters known as biosynthetic gene clusters (BGCs) 
along with resistance gene and transcriptional gene regulators to control the biosynthesis 
process (Adegboye and Babalola, 2012). 
Genome sequencing has revealed that Streptomyces contain many biosynthetic gene 
clusters that are poorly expressed or silent and therefore their corresponding secondary 
metabolites are not detectable (Cao et al., 2016).  These species have the potential to produce 
more natural products than initially detected. This has stimulated researchers to sequence and 
analyse the genomes of species to identify novel BGCs (Gross, 2009; Medema et al., 2011) 
and study the conditions required to induce the production of their corresponding metabolites 
in vitro (Tyc et al., 2014). 
The main aim of this thesis was to isolate novel Streptomyces isolates with antibacterial 
and antitumour activity and to identify the secondary metabolites they produce. In this study, 
we have isolated and characterized seven Streptomyces isolates from different areas of the 
UAE (unexplored habitat). Six isolates (CSK1, CSK3, CSW2, CSU1, CSU2 and CSG1) 
showed an inhibitory effect against E. coli, S. aureus, C. albicans, S. cerevisiae and E. coli-
ESBL as determined using minimum inhibitory concentration and well diffusion methods. The 
seventh isolate, CSM1, did not show any inhibitory effect against any of the tested bacteria. 
We also showed that some of the isolates had cytotoxic activity when tested against HeLa 
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cancer cells. Isolates CSK3, CSW2, CSU1 and CSG1 inhibited the growth of HeLa cells with 
IC50 values ranging from 3.46 µg/µl for CSK3 to 9.74 µg/µl for CSU1.  
In nature, bacteria are never found as single species but as part of a community where they 
are consistently interacting with their own species or other organisms (Braga et al., 2016). Soil 
contains a diverse and dense microbial community with prokaryotic population between 107 
to 1010 cells/g soil (Uroz et al.2010). This heterogeneous and nutrient poor soil environment 
involves the exchange of molecular and genetic information between organisms in a variety of 
mechanisms and molecules such as secondary metabolites, siderophores and quorum sensing 
in response to an environmental stimulus (Braga et al., 2016). The production of secondary 
metabolites by bacteria in the soil is a survival strategy to defend their host, compete for 
nutrients or fight off predators (Demoling et al., 2007). As part of communication, 
Streptomyces are able to produce and sense chemical signals with neighbouring organisms. 
Chemical compounds such as γ-butyrolactones (GBL, signalling molecule) and N-
acetylglucosamine (GlcNAc, an amino sugar) that are found in Streptomyces habitat but not in 
the culture media in vitro may play an important role as signals in the activation of silent 
metabolites (Niu et al., 2016). In addition, Streptomyces secondary metabolism can be 
stimulated by elicitation which is based on introducing cell extracts of a competing species 
(such as heat killed cells of B. subtilis) in order to mimic the interspecies interactions in nature 
and results in the production of antimicrobial compounds (Radman et al., 2003). 
Cultivation with heat killed cells of B. subtilis, ϒ-Butyrolactone or N-acetylglucosamine 
was performed on the six isolates to enhance the activity of the produced secondary metabolites 
or activate the expression of cryptic secondary metabolite biosynthetic gene clusters. 
Interestingly, the colour of cultured CSK1 changed to red when cultivated with B. subtilis and 
N-acetylglucosamine and activity against S. aureus was observed after 6 days of culturing 
compared to the monoculture which normally shows inhibitory activity after 14 days of 
culturing. In addition, cytotoxicity of the extracts isolated from cultivating CSK1 isolate with 
B. subtilis and N-acetylglucosamine caused inhibition of growth of HeLa cells compared to no 
inhibition of the CSK1 monoculture extract. This clearly shows a change in the bioactive genes 
produced from the CSK1 monoculture and CSK1 cultures with elicitors.  
The generation of biosynthetic genes from elicitation could be due to microbial competition 
and thus activation of production of cryptic bioactive molecules as a means of survival or 
antagonism (Abdelmohsen, 2015). The change in colour to red could be due to the production 
of undecylprodigiosin an antibiotic known to be produced by S. coelicolor (White and Bibb, 
1997). But, based on antiSMASH results, the BGC encoding for undecylprodiginines was not 
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detected for CSK1 isolate. The colour change may be due to a pH change and this needs to be 
investigated further. Also, the earlier inhibitory effect of the isolate can be due to the 
environmental changes that take place in the cultivation because of changes in growth, 
signalling molecules or from changes in nutrition (Marmann et al., 2014). The results could 
also imply that the elicitation of the biosynthetic genes could be due to the bacterial cell wall. 
B. subtilis as a Gram positive bacterium contains a cell wall with thick peptidoglycan which 
maintains the cell shape of the bacteria. Changes or interruption in the cell that could have 
occurred due to cell lysis or heating can lead to the peptidoglycan acting as a signalling 
molecule (Peterson et al., 2006) as peptidoglycan fragments have been found to play an 
important role in interspecies interactions  (Koropatnick et al., 2004) in which it can act as a 
carbon and nitrogen source (Peterson et al., 2006) to the Streptomyces species. Rigali et al., 
2006 have shown that N-acetyl glucosamine, which is one of the main components of the 
peptidoglycan, can trigger antibiotic production in Streptomyces. Addition of this monomer to 
the CSK1 culture could have stimulated the production of undecylprodigiosin observed by the 
red colour in the medium.  
Genomic sequencing analysis of the seven isolates (CSK1, CSK3, CSW2, CSU1, CSU2, 
CSG1 and CSM1) revealed a genome size, GC content and other features that are typical of 
Streptomyces. The 16S rRNA clearly show that the isolates belong to the Streptomyces genus 
that were isolated from soil. Based on whole genome blast, the isolates were closely related to 
Streptomyces sp. ETH9427 (draft genome sequence; accession number: NZ_CP029624.1; 
Thibessard et al., 2018) which was previously identified as S. ambofaciens. S. ambofaciens 
bacterium is found in soil, it produces the antitumour oligopeptide netropsin and macrolide 
antibiotic spiramycin (Juguet et al., 2009). AntiSMASH results of S. ambofaciens showed 25 
BGCs with many silent clusters in its genome such as kinomycins, stambomycins and 
antimycins (Aigle et al., 2014). As for the 16S rRNA blast, it showed CSK1, CSW2, CSU2 
and CSG1 to be closely correlated with Streptomyces sp. E2N17 (accession number: 
KX279529.1), a strain deposited into NCBI but with no studies in the literature; CSU1 and 
CSK3 with Streptomyces sp. ETH9427 which is also not studied (draft genome sequence) and 
CSM1 with S. albogriseolus strain ABRIINW EA1145 (draft genome sequence; accession 
number GQ925802.1). S. albogriseolus is a bacterium isolated from soil and produces 
neomycin B and neomycin C (Benedict et al., 1954) but ABRIINW EA1145 strain is not 
identified in the literature. Since there is no available literature on the strains that are closely 
related to our isolates, it was hard to correlate the BGCs of the isolated strains to known strains.  
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The number of BGCs, predicted by antiSMASH, in the genomes ranged between 25 to 29 
and some NRPS clusters in CSK1, CSK3 and CSU2 did not appear to encode production of 
any known molecules which may be of particular interest as this may indicate potential to 
produce novel secondary metabolites. Genomic analysis predicted that all isolates carry 
biosynthetic gene clusters that are capable of producing a variety of secondary metabolites and 
some of these metabolites were identified by LESA analysis. The variety of BGCs in each 
isolate confirms the potential of these isolates to produce a diverse range of compounds 
(Sekurova et al., 2019). All isolates, except for CSM1, carried clusters encoding production of 
antimycin (antifungal) and naphthyridinomycin (antimicrobial and antitumour) metabolites. 
Chlorizidine_A and herboxidiene, both antitumour agents, were identified in CSK1. 
Interestingly, CSK1 extract did not show any cytotoxic activity against HeLa cells but when 
cultivated with B. subtilis lysate, γ-Butyrolactone and GlcNAc an anti-proliferative effect was 
observed. This may imply that silent BGCs were activated by the effect of these different 
elicitors.  
Siderophores are small molecules that form stable compounds with ferric iron (Miethke 
and Marahiel, 2007). In iron deficient environments microorganisms produce siderophores to 
chelate ferric iron. Biosynthetic genes for siderophores such as desferrioxamine_B were also 
identified in the isolates. More than 10 Streptomyces species have been found to be capable to 
produce desferrioxamine B, E and G (Challis and Hopwood, 2003). In addition, in silico 
analysis of S. coelicolor sequence implied that many nonribosomal peptide synthetase (NRPS) 
pathways are used to assemble the structure of many siderophores (Bentley et al., 2002) such 
as the ones encoding for coelichelin (isolate CSM1; Challis and Ravel, 2000). 
All Streptomyces genomes were found to have a single ectoine biosynthesis gene cluster 
(Remali et al., 2017). The presence of ectoines in nature implicates important applications such 
as therapeutic uses and protective agents for cellular components (Pastor et al., 2010). The 
ectoine biosynthetic gene cluster was identified in all isolates. In addition, other post-
translationally modified peptides such as bacteriocin was predicted by antiSMASH in the 
isolates. 
A variety of molecules were separated using Liquid Extraction Surface Analysis (LESA) 
system (Kertesz and Berkel, 2010), a novel approach to detect metabolites directly from the 
Streptomyces colonies. The technique was also used for the assessment of metabolites in the 
non-induced colonies versus colonies induced with GBL and GLcNAc. A clear change in the 
spectral profile of the uninduced vs induced isolates was observed, indicating that the produced 
metabolites are different between the uninduced, induced with GBL and induced with GlcNAc 
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colonies. Some of the metabolites predicted by antiSMASH were confirmed by LESA 
including ectoine, cetoniacytone, hopene, arginomycin, desferrioxamine_B, meilingmycin, 
meridamycin and sanglifehrin_A for CSK1. Tables 5.4-5.10 summarizes the secondary 
metabolites predicted by antiSMASH and confirmed with LESA for all the isolates. These 
results affirm the potential of these isolates to produce a variety of natural products. 
In conclusion, effective secondary metabolites are required especially with the increased 
emergence of drug resistant organisms and toxicity of some drugs. The present study indicates 
that six different isolates with antimicrobial and anticancer activity were isolated from 
terrestrial habitats in UAE. The genomic sequencing and LESA results have predicted and 
identified respectively that these organisms are capable of producing a variety of secondary 
metabolites. We have, also, showed that exposing these isolates to biological or chemical 
elicitors such as B. subtilis, γ-butyrolactone and N-acetylglucosamine is an excellent way to 
induce the expression of genes encoding bioactive products which can lead to the production 
of novel secondary metabolites. 
 
 Future Work 
There are many approaches that can be used to activate silent secondary metabolite-
biosynthetic gene clusters (SM-BGCs). For example, studying and optimizing culture 
conditions such as carbon, nitrogen and phosphorus (Nazari et al., 2013) based on the one 
strain many compounds (OSMAC) approach. Changes in the composition of the growth media 
may result in the production of new molecules, although this may be a strenuous approach it 
is still commonly used. Genetic engineering techniques such as promoter exchange, ribosome 
engineering, inactivation of negative regulatory genes or activation of positive regulatory 
genes have also been used to activate silent SM-BGCs (Ochi, 2017). Another cost-effective 
and simple approach is co-culturing the isolates with other microorganisms mimicking the 
microbial interactions that are happening in the natural habitat that can trigger the expression 
of silent biosynthetic gene clusters encoding for seconding metabolite production (Antoraz et 
al., 2015).  
The focus for future experimental work based on Genome sequencing and LESA-MS 
results would be to isolate and characterize the bioactive molecules that may have novel 
biological activity. In order of priority, I would first identify the peptides identified by Norine 
database but not by antiSMASH such as CSK1_region 191.1, CSU2_region 615.1, 
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CSK3_region 476.1 and CSK3_region 5471.1. Then, further identify the peptides that do not 
show any homology to known peptides by both Norine and antiSMASH databases such as 
CSK1_region 350.1, CSK1_region 471.1 and CSU2_region 570.1.  
Connecting genes to a compound is one of the approaches that can be used to activate the 
expression of silent biosynthetic gene cluster where you can identify unknown peptides by 
using the sequence of the genes encoding its synthesis (Challis and Ravel, 2000). A product of 
a novel BGC can be identified by inactivating a specific biosynthetic gene along with 
comparative metabolic analysis of the wildtype and mutant strains using HPLC (Sekurova et 
al., 2019). This approach does not require the metabolite, encoded by the silent BGC, to be 
active and primarily relies on the comparison of the two metabolic profiles. This approach was 
used to identify coelichelin from S. coelicolor, a silent NRPS gene cluster was inactivated and 
the correlation of the BGC to its metabolite was made by comparative metabolomics (Lautru 
et al., 2005). 
Studies have shown that many pleiotropic regulators affect secondary metabolism in 
Streptomyces (van Wezel and McDowall, 2011). The afsQ two-component system is one of 
these regulators (Liu et al., 2019). These genes are conserved in many Streptomyces and studies 
showed that it can regulate the production of secondary metabolites (McKenzie et al., 2010).  
A study done by Daniel-Ivad et al. (2017) showed that expressing an activated allele of afsQ1, 
generated from S. coelicolor, lead to the production of a variety of secondary metabolites in 
many Streptomyces strains with antibacterial activity. A similar approach can be used on our 
isolated Streptomyces strains to activate and generate the unknown compounds. 
 Another important approach to enhance or activate SM-BGCs is by overexpressing the 
abrC3 response regulator. Studies have shown that abrC3 can positively control the production 
of actinorhodin and undecylprodiginine production in addition to morphological 
differentiation in S. coelicolor (Rico et al., 2014). A construct containing abrC3 can be 
introduced into the isolate of interest and the recombinant strain can be grown in appropriate 
media. Organic extracts can then be analysed by HPLC-MS and compared to the control strain 
(empty vector). 
Future studies at the molecular level must be implemented in the discovery of novel 
secondary metabolites since we don’t have enough information about the signals that are 
required for their production. One important molecular tool is the CRISPR-Cas9 (clustered 
regulatory interspaced short palindromic repeats and CRISPR-associated protein 9) system as 
a tool for genome engineering in Streptomyces isolates. The system provides adaptive 
immunity in many bacteria and archaea. Studies have shown that engineered CRISPR-Cas9-
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based technology can be used to edit biosynthetic gene clusters by deleting genes or gene 
clusters and conduct gene replacements (Cobb et al., 2014). Engineered CRISPR-Cas9 can be 
used to knock-in constitutive promoters upstream of known biosynthetic gene clusters in a well 
characterized model of Streptomyces strains (Cobb et al., 2014). This method can, also, be used 
to produce novel natural products by knocking in active promoter upstream of the cluster to 
induce production of possibly new secondary metabolites (Zhang et al., 2017). 
Changing the host for heterologous expression is another tool that has many advantages 
such as not using the natural regulatory system of the native host (as some genetic editing tools 
are not easy to use in some Streptomyces hosts) and surpasses the challenging genetic 
manipulation of the native host (Xu and Wright, 2019). The best host for heterologous 
expression is the Streptomyces species for the production of natural products, because they 
have a variety of cofactors, enzymes and precursors; they have complicated post modification 
arrangements such as acetylation, phosphorylation and glycosylation; they have resistance and 
tolerance genes; and appropriate protein folding to process multi-enzyme complexes (Liu et 
al., 2018). The most commonly used hosts include S. coelicolor, S. lividans and S. avermitilis 
(Zhao et al., 2019). The genome minimizing approach has, previously, played a major role in 
the discovery and overexpression of natural products. For example, a 1.4 Mb region was 
deleted from S. avermitilis, by Komatsu et al., 2010, to remove nonessential genes and produce 
a series of specific deletion mutants that did not produce any of the secondary metabolites 
found in the wild type strain. SUKA17 and SUKA22 generated mutants were tested for their 
high efficiency heterologous expression of unknown metabolites such as cephamycin C from 
S. clavuligerus and streptomycin from S. griseus (Komatsu et al., 2010). BGCs can be cloned 
into these mutants’ model host and transformants carrying the gene cluster may produce 
metabolites due to the expression of the introduced biosynthetic gene clusters (Komatsu et al., 
2013).  
Another approach that can be used to activate silent BGCs is high-throughput elicitor 
screening (HiTES) to identify small molecule signals in order to induce BGCs. This can be 
done by inserting a reporter gene into the biosynthetic gene cluster of interest which provides 
read-out of its expression. Then, small molecule libraries can be screened for potential elicitors 
(Okada and Seyedsayamdost, 2017).  
 Ribosome engineering is an emerging approach to discover organisms with specific 
spontaneous mutation in their ribosome or RNA polymerase through screening antibiotic-
resistant mutants. Selected mutants may have changes in secondary metabolite production or 
produce new natural products with unusual biological activities (Zhu et al., 2019). Ochi’s 
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group in 2009 screened 1068 actinomycetes from soil grown on antibiotics to select antibiotic 
resistance strains (Hosaka et al., 2009). They showed that they were able to isolate a number 
of novel macrocyclic piperidamycin from one soil strain with either a single or double mutation 
in rpoB (encoding the RNA polymerase (RNAP) β-subunits) and rspl (encoding the ribosomal 
protein S12). This confirms that mutations in ribosomal proteins or RNAP changes bacterial 
gene expression leading to the improvement of production strains or inducing silent 
biosynthetic gene clusters (Okada and Seyedsayamdost, 2017). 
 In summary, the results of our Next Generation Sequencing (NGS) and Liquid 
Extraction Surface analysis (LESA) have revealed that these isolates have a great potential to 
produce novel secondary metabolites. We can make tremendous progress in activating silent 
genes or discovering cryptic gene products if we adopt one of the above synthetic biology 
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BGCs identified by antiSMASH and confirmed with LESA spectra (in reference to Tables 5.4-5.10) 
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